US5167950A - High alcohol content aerosol antimicrobial mousse - Google Patents

High alcohol content aerosol antimicrobial mousse Download PDF

Info

Publication number
US5167950A
US5167950A US07/676,917 US67691791A US5167950A US 5167950 A US5167950 A US 5167950A US 67691791 A US67691791 A US 67691791A US 5167950 A US5167950 A US 5167950A
Authority
US
United States
Prior art keywords
alcohol
weight
intermediate concentrate
foam
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/676,917
Inventor
Claudio L. K. Lins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SC Johnson and Son Inc
Original Assignee
SC Johnson and Son Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SC Johnson and Son Inc filed Critical SC Johnson and Son Inc
Priority to US07/676,917 priority Critical patent/US5167950A/en
Assigned to S.C. JOHNSON & SON reassignment S.C. JOHNSON & SON ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: LINS, CLAUDIO L. K.
Application granted granted Critical
Publication of US5167950A publication Critical patent/US5167950A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16—Foams
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Definitions

  • the invention relates to an aerosol antimicrobial mousse-producing composition with a high level of alcohol as an active ingredient.
  • the composition delivers a stable, disinfecting foam which breaks on pressure application to provide a creamy film of an alcoholic disinfectant.
  • compositions containing at least 52% by weight of ethanol or isopropyl alcohol are antibacterial and, thus, widely accepted for disinfecting purposes.
  • compositions with high alcohol content for disinfecting the hands are available as an antimicrobial alcoholic gel as described in U.S. Pat. No. 4,956,170 to Lee. While using gels to deliver an alcoholic disinfectant is satisfactory for many purposes, nonetheless, where patients have suffered burns or where skin conditions do not permit the spreading of a gel over an area to be treated, there exists a need for an alternate delivery system. That delivery system must be capable of providing disinfectant over an irritated or sensitive area without the pressure required to spread a gel.
  • a semi-solid mass contains alcohol applied to the skin by massaging.
  • the gelling agent used to make the alcohol mass semi-solid may be a soap and a wax.
  • the alcoholic composition is dispersed on the skin by rubbing.
  • the composition is unsuitable for application to highly sensitive skin.
  • Alcohol containing moisturizing products dispensed as foams are known, as disclosed in Bennett's The Chemical Formulary, Volume XVI, page 109 (1971), wherein a formulation of a "Fluff-Type Aerosol Moisturizing Cologne” containing 46% alcohol and having a fluorocarbon propellant is recited.
  • the formulation for a Foam-Moisturizing product in The Chemical Formulary, Volume XX, page 194 (1977) includes 35% alcohol, 40% of a 1% solution of Carbopol®941 (as a thickener) neutralized by diisopropanolamine, and a fluorocarbon propellant.
  • Such alcoholic foaming formulations however, have concentrations of alcohol lower than the 52% concentration normally required for suitable antimicrobial activity. Additionally, use of fluorocarbon propellants is undesirable for the deleterious effect on the environment and the solubility problems they present.
  • Mousse-forming compositions can be employed to cleanse skin as taught in U.S. Pat. No. 4,806,262 to Snyder. However, such preparations do not possess the high alcohol content required for antibacterial effect.
  • the alcohol employed in amounts to 5% is used as an emollient and a mousse stabilizer.
  • the propellants used in Snyder, nitrous oxide, carbon dioxide and nitrogen do not form a stable foam in the inventive compositions.
  • mousse includes a composition which is dispensed as a foam and which remains in that form until mechanically compressed as by rubbing or touching. It is, therefore, necessary to provide a stable foam which will not collapse until subjected to the pressure of a mechanical action. However, the presence of alcohols in high concentration, until now, has often caused foams to collapse.
  • the solubility characteristics of the chlorofluorocarbons differ from the hydrocarbon propellant used in the present invention.
  • chloroflurocarbons there is a problem of the incomplete solubility of the combination of surfactants in the aerosol. That results in the possibility of valve clogging and the formation of unstable foams.
  • the '152 Klausner patent does not teach use of a polymeric gelling agent or an amphiphilic nonionic stabilizer with a specific HLB.
  • a readily-collapsible, antiperspirant sprayable foam composition is taught in U.S. Pat. No. 3,395,214 to Mummert.
  • the composition has 20-60% alcohol and 10-70% water. Cetyl alcohol is employed and an ethoxylated stearyl alcohol is used together with a thickener and antiperspirant. Freon, propane or isobutane were employed as the propellants. However, the surfactants employed in Mummert are not completely soluble with hydrocarbon propellants which results in precipitation thereof and clogged valves when the foam is dispensed.
  • the Mummert foams also disappear within a few seconds after dispensing and before any mechanical working of the dispensed material.
  • the thickener employed in Mummert was a magnesium aluminum silicate ("Veegum"). It is believed that the undesired "Veegum” together with the surfactant used renders the compositions too unstable and unduly insoluble in the aerosol form.
  • U.S. Pat. No. 476,273 to Grollier et al. teaches an unstable aerosol foam containing cationic and/or anionic polymers that produce a foam in an aqueous solution.
  • the alcohol content (C 1-8 alcohol) is said not to be more than 50%.
  • U.K. Pat. No. 1,096,753 to Yardley & Co. Ltd. (equivalent to U.S. Pat. No. 3,824,303) relates to a collapsible foam pre-electric shave lotion.
  • the foam is formed from a 55-70% water:alcohol solution which contains 0.5 to 5% of a surfactant mixture which is an ester or ether of a higher monohydric or dihydric alcohol having eight or more carbon atoms and a higher alcohol.
  • Hydrocarbon propellants can be used.
  • the composition does not form a stable foam, lacks a polymeric gelling agent and does not teach the HLB balance of the present invention.
  • U.S. Pat. No. 4,627,973 to Moran et al. relates to an aerosol skin mousse containing a combination of moisturizers.
  • the alcohol content is only 15-30% by weight.
  • U.S. Pat. No. 3,770,648 to Mackles is directed to an anhydrous aerosol foam.
  • Mackles Example I4 relates to a hair cleaning foam containing 45% ethanol and only 5% water.
  • a silicone resin is the foaming agent and a fluorocarbon propellant is used.
  • Examples 16 and 17 disclose anhydrous antiperspirant foams containing 74% and 81% alcohol respectively.
  • a silicone resin is the foaming agent and a fluorocarbon propellant is employed.
  • U.S. Pat. No. 4,440,653 to Briscoe et al. teaches a stable alcoholic foam to be used as a carrier fluid such as a treating fluid for subterranean oil wells.
  • the composition contains a liquid phase of 50-100% alcohol, which may optionally contain water.
  • a nonionic surfactant and thickening agent, such as guar gum, are combined in the alcoholic solution.
  • the liquid is foamed with a gas or mixture of gases such as air, carbon dioxide or preferably nitrogen.
  • the foam-forming gases used in Briscoe are not hydrocarbon propellants.
  • Briscoe fails to employ an amphiphilic nonionic stabilizer or a higher alcohol and a polyethoxylated fatty alcohol. The foam merely functions to stimulate recovery of hydrocarbons (oil) in subterranean formations.
  • U.S. Pat. No. 4,511,486 to Shah teaches cleaning dentures with an aerated foam.
  • the foamable liquid cleanser includes 1-10% surfactant, 0.1-10% humectant, 25-60% water and 35-70% ethanol or isopropyl alcohol.
  • the foam is non-pressurized. In use the cleaner is forced into an air-mixer to form a foam.
  • U.S. Pat. No. 4,808,388 to Beutler et al. relates to a foamable cream for the skin which may be in the form of a mousse.
  • Beutler teaches a creamy, oil-in-water emulsion using nitrous oxide or carbon dioxide as the propellant.
  • Alcohols of long-chain fatty acids in concentrations of 0.5-4.5% are employed, but no ethanol or isopropanol is used.
  • U.S. Pat. No. 4,673,569 to Shernov et al. is directed to a mousse aerosol hair composition having water and alcohol phases.
  • the alcohol phase includes 0.5% to 20% of an alcohol, such as ethanol, as a secondary solvent.
  • the alcohol phase further contains a long-chain nonionic ester and a foam-forming agent.
  • the water phase contains water, a film-forming resin and a corrosion inhibitor.
  • the mousse composition also contains ammonium hydroxide with isobutane as the propellant.
  • U.S. Pat. No. 3,840,465 to Knowles et al. discloses a foam-producing composition including an aqueous solution of a foam-producing surfactant containing a propellant dispersed therein.
  • the composition further includes a water-insoluble surfactant which is soluble in the propellant.
  • the foam-producing surfactant is a fatty acid salt or synthetic surfactant and the propellant-soluble surfactant is an ethoxylated compound.
  • the composition provides a very persistent foam which is said to last from 40 to 240 minutes. There is no disclosure of high amounts of alcohol being present nor of the collapse of the foam upon being subjected to pressure.
  • This invention encompasses a high alcohol content aerosol antimicrobial mousse composition which includes (I) an intermediate concentrate in amounts from about 85% to 98% of the total weight of the mousse composition and (II) a propellant in amounts from about 2% to 15% of the total weight of the mousse composition.
  • the intermediate concentrate includes from about 52% to 75% by weight of ethanol, isopropanol or mixtures thereof; from about 0.1 to 1.5% by weight of a water-dispersible polymeric gelling agent; from about 1.0% to 15% by weight of an amphiphilic nonionic stabilizer comprising (a) from about 0.5 to 5.0% by weight of at least one alcohol of the formula ROH, wherein R is a hydrocarbon group having from 16 to 22 carbon atoms and (b) from about 0.5% to 10% by weight of at least one nonionic surfactant of the formula R,O(CH2CH20)xH where R' is a hydrocarbon group having from 16 to 22 carbon atoms and x has an average value of 1 to 21, wherein the hydrophilic and lipophilic balance (HLB) of the combination of (a) and (b) is from about 4.5 to 8.0; and the balance being at least about 20% by weight of water.
  • HLB hydrophilic and lipophilic balance
  • the propellant is at least one saturated aliphatic hydrocarbon having from 2 to 6 carbon atoms per molecule.
  • the propellant generally has a vapor pressure of about 17 to 108 pounds per square inch (0.12 to 0.74 MegaPascal - "MPa”) gauge at 25° C.
  • the mousse delivery form is superior to a gel delivery form for sensitive skin because the alcohol disinfectant remains stabilized in the dispensed mousse foam for a longer period.
  • the gel on the other hand, is applied to a small area of the skin and then spread in expanding circles. Since the alcohol tends to evaporate from the gel almost immediately, there is little alcohol left at the edges of the expanding circles. However, when the mousse foam is applied, the alcohol remains stabilized in the mousse for a longer period of time.
  • the invention is directed to a high alcohol content mousse adapted for disinfectant and hospital uses. It is recognized by the Food and Drug Administration that a composition having a minimum of about 54% by weight of ethanol is considered to be antimicrobial because it is capable of killing gram positive and gram negative bacteria upon contact.
  • the mousse form of the composition stabilizes the alcohol against immediate evaporation. When a measured amount of the mousse composition is applied to skin previously contaminated with bacteria, the bacterial colony count is typically reduced by a factor on the order of 10,000 times.
  • the mousse composition of the invention includes an intermediate concentrate of active ingredients and a hydrocarbon propellant for the intermediate concentrate.
  • the intermediate concentrate includes an alcohol, a gelling agent, an amphiphilic nonionic stabilizer, and an aqueous carrier.
  • the antimicrobial effect of the present invention is best evidenced in the presence of about 52% to 75% by weight of an alcohol, preferably ethanol or isopropyl alcohol, or mixtures thereof.
  • the alcohol may be either pure alcohol or denatured alcohol.
  • a more preferred alcohol is ethanol and, most preferably, a denatured alcohol, Specially Denatured (SD) Alcohol 40-A.
  • SD Alcohol 40-A is anhydrous alcohol which is denatured with t-butyl alcohol and sucrose octaacetate.
  • the intermediate concentrate should contain a gelling agent (or thickening agent).
  • the gelling agent preferably employed is a water-dispersible polymeric gelling agent.
  • a more preferred gelling agent is an addition polymer of acrylic acid crosslinked with an unsaturated polyfunctional agent, such as polyalkyl ether of sucrose.
  • the gelling agent assists in stabilizing the formulation to avoid early crystallization prior to filling in the dispenser.
  • the intermediate concentrate is made thicker by the gelling agent for better mixing with the propellant to thus produce a more stable foam.
  • Preferred polymeric gelling agents are described in U.S. Pat. Nos. 2,798,053, 3,,133,865 and 4,956,170, the disclosures of which are incorporated by reference. They are also to be found listed in the CTFA (Cosmetic, Toiletry, and Fragrance Association), 3rd Edition, 1982, under the adoptive name "Carbomer.” They are commercially available under the tradenames CARBOPOL® 934, 940, 941, 951 from B.F. Goodrich Chemicals Group of Cleveland, Ohio. Carbomer 951 is a more preferred gelling agent. Carbomer 951 is the same product as Carbomer 941, except that it is prepared in a benzene-free system, since the solvent used in its production is ethyl acetate.
  • Effective gelling agents are also available under the trade names ACRITAMER 934, 940 and 941 from R.I.T.A. Corporation of Crystal Lake, Illinois. Other thickening polymers and gums may be used according to their compatibility with the hydroalcoholic system. Other such suitable gelling agents include cellulosic ether polymers sold by Dow Chemical as Methocel® and hydroxymethyl, hydroxyethyl and hydroxypropyl cellulose gums sold under the mark Aqualon®.
  • the gelling ability of the preferred acrylic polymer thickeners is affected by the high alcohol content of the concentrate, it is best to maintain their gelling capability by neutralizing them. Accordingly, optimum thickening results are attained when the carboxyl groups present in the acrylic acid polymers are neutralized employing a suitable neutralizing agent sufficient to render the polymers more water soluble. Usually, from about 15 to 100% of the carboxyl groups present in the acrylic acid polymer are neutralized. Preferably at least about 50% of the carboxyl groups are neutralized.
  • Appropriate neutralizing agents include triethanolamine, sodium hydroxide, monoethanolamine and dimethyl stearylamine.
  • Other neutralizing agents may be used, such as HO(C m H 2m ) 2 NH where m has the value of from 2 to 3 and aminomethyl propanol, aminomethyl propanediol, and ethoxylated amines, i.e., H(OCH 2 CH 2 )xRN(CH 2 CH 2 O)yH, where R is a hydrocarbon radical having from 10 to 18 carbon atoms and the sum of x+y has an average value of from about 5 to 25.
  • PEG-25 cocamine hydrocarbon groups are derived from coconut fatty acid and the sum of x+y is 25.
  • suitable ethoxylated amines are polyoxyethylene (5) cocamine ("PEG-5 cocamine”); polyoxyethylene (25) cocamine (“PEG-25 cocamine”); polyoxyethylene (5) octadecylamine ("PEG-5 stearamine”); polyoxyethylene (25) octadecylamine (“PEG-25 stearamine”); polyoxyethylene (5) tallowamine (“PEG-5 tallowamine”); polyoxyethylene (I5) oleylamine (“PEG-15 oleylamine”); polyethylene (5) soyamine (“PEG-5 soyamine”); and polyoxyethylene (25) soyamine (“PEG-I5) soyamine”).
  • a number of these are commercially available under the tradename of ETHOMEEN from Akzo Chemie America, Armak Chemicals of Chicago, Illinois.
  • the preferred neutralizing agent is triethanolamine (TEA).
  • the polymeric gelling agent is employed in amounts sufficient to provide the intermediate concentrate with sufficient viscosity, to render it pourable and to form a stabilized foam with the propellants.
  • the polymeric gelling agent is employed in amounts sufficient to provide the intermediate concentrate with sufficient viscosity, to render it pourable and to form a stabilized foam with the propellants.
  • from about 0.1 to 1.5% by weight of the water-dispersible polymeric gelling agent is employed. More preferably from about 0.I to 0.8% by weight is employed.
  • the mousse composition is generally formulated as an emulsion having a water-alcohol phase, which includes the active ingredients. It is believed that a small portion of the hydrocarbon propellant is also solubilized in the water-alcohol phase. The balance of the propellant forms a separate layer. Upon discharge, the propellant solubilized in the water-alcohol phase expands and generates the stable aerosol mousse. For that and other purposes, it is necessary to formulate the mousse composition as a stable emulsion.
  • the amphiphilic system of a long-chain alcohol and a nonionic surfactant, properly HLB balanced acts to overcome the problem of phase separation when using hydrocarbon propellants and permits the intermediate concentrate to retain sufficient propellant to produce a stable foam upon discharge. In addition, the amphiphilic stabilizer remains stable upon pressurization with propellant and resists the tendency to desolubilize and to release components which could clog the aerosol valve.
  • the foam viscosity of the mousse foam is an indicator of the stability of the dispensed mousse.
  • the foam viscosity at room temperature (20° -22° C.) should be from 2,000 to 40,000 centipoise --"cps" (2 to 40 pascal seconds --"Pa.s"), preferably from 15,000 to 30,000 cps (15 to 30 Pa.s), as measured by a Brookfield Heliopath digital LVTD Viscosimeter with a T-bar spindle at 12 rpm.
  • An important feature of the present invention is the presence of a mixture of a relatively long-chain alcohol and at least one nonionic surfactant to form an amphiphilic nonionic stabilizer system.
  • the amphiphilic nonionic stabilizer system provides stable compositions when using the hydrocarbon propellants.
  • the nonionic stabilizers employed are selected so as to have a hydrophile-lipophile balance (HLB) between 4.5 to 8.
  • HLB hydrophile-lipophile balance
  • the HLB between the long-chain alcohol and the nonionic surfactant must be within the range of 4.5 to 8 so as to prevent the water-alcohol actives from desolubilizing and permitting solid precipitants or agglomerates to clog the orifice of the spray container.
  • the test results have shown that when the HLB of the long-chain alcohol and nonionic emulsifier is between about 4.5 and 8, then the intermediate concentrate is translucent and generally homogeneous. The resulting foam is creamy and exhibits a satisfactory foam viscosity.
  • the HLB is adjusted to 7.5, a very creamy stable foam with a foam viscosity on the order of 31,000 cps (31 Pa.s) may be obtained.
  • the HLB value was below about 4.5, then excessively creamy foams were produced which exhibited a reduced foam viscosity.
  • Samples with an HLB value of 4.9 exhibited a creamy foam and yielded generally a viscosity reading of over 20,000 cps (20 Pa.s).
  • Samples with HLB values of 9.7 provided oily or tacky foams with reduced viscosities on the order of 15,000 cps (15 Pa.s).
  • the long-chain alcohol of the amphiphilic stabilizer has the preferred formula ROH, wherein R is a hydrocarbon group of 16 to 22 carbon atoms.
  • Typical alcohols include cetyl, stearyl, isostearyl, hydroxy stearyl, oleyl, ricinoleyl, behenyl, erucyl and 2-octadecenyl alcohols.
  • the long-chain alcohol is employed in amounts sufficient to provide stabilizing effects.
  • the nonionic surfactant preferably has the formula:
  • R' is an aliphatic hydrocarbon group having 16-22 carbons and x has an average value from 1-21.
  • Such surfactants are polyethoxylated fatty alcohols.
  • the R'O-group can be derived from alcohols such as cetyl (C 16 ), stearyl (C 18 ), oleyl (C18), behenyl (C 20 ) and erucyl (C 22 ) alcohols. Lauryl alcohol, a C 12 alcohol and myristyl alcohol, a C 14 alcohol were unsatisfactory when employed as the fatty alcohol portion of the ethyloxylated fatty alcohol, since little or no foam was produced.
  • Typical preferred polyethoxylated fatty alcohols are the surfactants sold under the mark "BRIJ" by ICI Americas, Inc.
  • Typical preferred polyethoxylated fatty alcohols include polyethoxylated stearyl alcohol containing an average of 21 moles of ethylene oxide or an average of 2 moles of ethylene oxide.
  • polyethoxylated fatty alcohol in general, sufficient amounts of polyethoxylated fatty alcohol are employed to provide a stable intermediate concentrate and a stable foam.
  • from about 0.5-10% by weight is employed, more preferably 2.5% by weight.
  • more than one nonionic surfactant can be utilized.
  • cetearyl alcohol is available under the mark Ritapro 300 from R.I.T.A. Corp. in Crystal Lake, Illinois.
  • Cetearyl alcohol is a combination of a cetyl and stearyl alcohol and ceteareth-20 is a mixture of cetyl ethers and stearyl ethers of polyethylene oxide having an average of about 20 oxide units.
  • Sufficient water preferably deionized water, is used to form a stable intermediate concentrate. In general, at least about 20% by weight water is employed.
  • Compatible foam stabilizing and boosting surfactants can optionally be employed including lactic acid esters of monoglycerides sold under the mark “Lactodan” by Grinsted Products, Inc., of Industrial Airport, Kansas, as well as R'CON(CH 2 CH 2 OH)yH 2-y , where R' is an aliphatic hydrocarbon group of from 16 to 22 carbon atoms and y is 1 or 2.
  • These surfactants include cationic emulsifiers, such as diquaternized tallow imidazoline methosulfate, sold as Sherex Varisoft 6112 (available from Sherex Chemical Co. Inc.
  • a triquaternized stearic phospholipid complex sold as Monaquat P-TS (available from Mono Industries, Inc., Patterson, New Jersey); hydroxystearamide propyltriamine salts, such as stearamide diethanolamine cyclamide, sold as Cas Chem Surfactols (available from Cyclo Chemicals Corp., Miami, Florida); lactic acid monoglycerides and food emulsifiers such as glyceryl monostearate, propylene glycol monostearate and sodium stearoyl lactylate.
  • a more preferred foam booster is a silicone wax or an encapsulated oil, such as stearoxytrimethylsilane and stearyl alcohol sold as Q5-0158A wax from Dow Corning and the 3M Microcapsule Mineral Oil.
  • foam stabilizers and boosters are preferably employed in amounts from about 0.1 to 1.0% by weight of the intermediate concentrate.
  • the hydrocarbon propellant employed is a saturated hydrocarbon or mixtures thereof.
  • the hydrocarbon should have 2 to 6 carbon atoms and includes ethane, n-propane, n-butane, n-pentane, n-hexane, isopropane, isobutane and mixtures thereof.
  • the propellant should preferably exert a vapor pressure between about 17 and 108 pounds per square (0.12 to 0.74 MPa) inch gauge at 25° C.
  • the propellant is employed in amounts from about 2-15% by weight based on the total weight of the mousse composition, and preferably in amounts of about 10% to provide a preferred pressure of 52 p.s.i.g. (0.36 MPa).
  • fragrances include fragrances, antimicrobial agents, skin protective agents, humectants, medicinal ingredients and other auxiliary materials which are conventionally used in cosmetic compositions.
  • Glycerine, propylene glycol and urea are typical moisturizing agents (i.e., humectants) which may optionally be incorporated into the mousse Medicinal substances such as salicylic acid and boric acid may also be added to the system as well as topical anesthetics, such as lidocaine.
  • moisturizing agents i.e., humectants
  • Medicinal substances such as salicylic acid and boric acid may also be added to the system as well as topical anesthetics, such as lidocaine.
  • Chlorhexidine digluconate is a preferred optional ingredient because it provides a long-term residual antimicrobial effect. It may be employed in amounts from about 0.1% to 8% by weight based on the intermediate concentrate.
  • the intermediate concentrate is employed in amounts from about 85-98% of the total mousse composition, although there may be circumstances which would permit more or less to be used.
  • the intermediate concentrate may be prepared by admixing the ethanol, isopropanol or mixtures thereof with the gelling agent and stirring. Next, in sequence, the water, preferably deionized water, is added; the gelling agent is neutralized as required and the amphiphilic stabilizers are added with heating, if necessary. After cooling, optional volatile ingredients can be added. The intermediate concentrate is then pressurized with the propellant.
  • compositions made in accordance with the above invention are employable in institutions such as hospitals, nursing homes and clinics or in the home where frequent contact with sources of bacteria and viruses are possible, and thus, a frequent need for degerming the hands arises.
  • the user simply dispenses a golf ball size of the mousse into the palm and rubs the mousse over the hands until they are dry.
  • the contact with the alcohol degerms the hands and if emollients and/or the humectants are employed, they can reduce the drying effects of the alcohol on the skin.
  • Typical ingredients employed in the mousse composition include:
  • Brij®72--Steareth-2 cetyl ether of polyethylene oxide having an average of about 2 ethylene oxide units
  • Brij®721--Steareth-21 (cetyl ether of polyethylene oxide having an average of about 21 ethylene oxide units) available from ICI America, Inc., Wilmington, Delaware.
  • Cyclomide®DS-280 1:1 Stearic diethanolamide from Alcolac, Inc.
  • Klucel®--hydroxy propylcellulose available from Hercules, Inc., Wilmington, Delaware.
  • Myvatex® Texture Lite Food Emulsifier - a combination of glyceryl monostearate, propylene glycol monostearate, and sodium stearoyl lactylate which is available from Eastman Chemical Products, Inc.
  • Ritapro®300 (RP-3021)--cetearyl alcohol and ceteareth-20 surfactant from R.I.T.A. Corporation, Crystal Lake, Illinois.
  • SD Alcohol 40A--anhydrous denatured alcohol
  • Triethanolamine (TEA).
  • Varisoft® 6112--tallow imidazoline methosulfate diquaternary available from Sherex Chemical Co. Inc. in Dublin, Ohio.
  • Veegum--a magnesium aluminum silicate which gels in water from R.T. Vanderbilt Co., Inc. of Norwalk, CT.
  • compositions of the present invention useful as antimicrobial mousse compositions.
  • the ingredients for the composition in parts are as follows:
  • the Carbomer 951 was added to the alcohol at room temperature and stirred for five minutes.
  • the deionized water was then added, and the mixture stirred for an additional five minutes.
  • TEA was then added and the mixture again stirred for five minutes.
  • the mixture was then heated to 120° -140° F. (48.9° -60° C.), and the Ritapro 300 was added and stirred until the entire amount was melted. After cooling down to 110° -100° F. (43.3° -37.8° C.), the fragrance was added.
  • the density of the intermediate was found to be 0.842 g/ml.
  • the product yielded a creamy stable foam with the following foam density and foam viscosity:
  • the foam density measurement at room temperature (20° -22° C.) was made by transferring 40 ml of foam to a 40 ml container, care being taken to minimize air pockets during the filling of the container.
  • the measurement was made by using a Brookfield Heliopath digital LVTD Viscosimeter.
  • the T-bar spindle E was used at 12 rpm, and measurement was made at room temperature (20° -22° C.) after a period of one minute.
  • the measured viscosity was 22,035 centipoise (22.035 Pa.s).
  • the measured foam viscosities were within the general desired range from 2,000 to 40,000 cps (2 to 40 Pa.s). The viscosity measurements and foam quality were more satisfactory when the concentration of Ritapro 300 was in the range of 4-5% weight.
  • Comparative Examples 1-8 were prepared to show the effect of employing lauryl alcohol, a C 12 alcohol (Comparative Examples 1-4) and myristyl alcohol, a C 14 alcohol (Comparative Examples 5-8) respectively, on foam viscosity.
  • the amount of Ritapro 300 was reduced in proportion to the amount of lauryl (or myristyl) alcohol added.
  • Formulations C. E. 1-8 were as follows:
  • Comparative Examples 5-8 were prepared in the same manner, except for substituting myristyl alcohol for lauryl alcohol.
  • Example 1 The following Examples were prepared according to the procedure in Example 1 to illustrate the effect of different hydrophilic-lipophilic balance (HLB) values obtained by varying the proportions of the surfactants Brij 72 and Brij 721 in combination with Ritapro 300 and using a propane propellant at high pressure.
  • HLB hydrophilic-lipophilic balance
  • Comparative Example 9 with an HLB of 4.9 provided creamy foam. At the HLB value of 7.5, a very cream, thick foam was obtained. The higher viscosity provided an extremely creamy foam which remained stable for a longer period of time, thereby increasing the availability of the alcohol due to slower evaporation of the alcohol.
  • the comparative examples with an HLB of values of 9.7, 12.8 and 15.5 provided foams which were either too airy and light or broke too quickly before mechanical working.
  • the purpose of the mousse composition of the present invention is to provide a stable foam which will not break before it is applied to the skin.
  • Example 2 was prepared according to the procedure in Example 1 to show use of a different mixture of hydrocarbons as the propellant.
  • Foam density--0.050 g/ml Foam density--0.050 g/ml.
  • chlorhexidine digluconate was employed as an antimicrobial agent which was added to extend the antimicrobial property of the mousse by providing a long-term residual killing effect.
  • Carbomer 951 which is an anionic water-dispersible polymeric gelling agent
  • a nonionic cellulosic thickener was used. That was deemed necessary since the chlorhexidine digluconate has a positive charge and may precipitate out the anionic agent. Varying amounts of the chlorhexidine digluconate were employed. The samples were prepared as in Example 7 using B-52 Propellant.
  • Example 1 The samples were analyzed and the measurements were made as in Example 1.
  • the following example includes a silicone wax and a humectant.
  • the mousse compositions were prepared and the foam measurements were made as in Example 1.
  • Q5-01584 is a foam booster which acts together with the Ritapro 300 to provide a very creamy foam.
  • Example 16 after the addition of the Varisoft 6112, a yellow precipitate was observed to form which remained in the viscous gel that formed.
  • Example 1 A formulation was prepared according to Example 1 to illustrate the use of a medicinal substance, such as salicylic acid and 2-phenoxyethanol, in the mousse compositions of the invention.
  • the preparation in Example 19 was made and tested as in Example 1 while Example 20 was made as in Example 7.
  • the ingredients were mixed together in the order listed.
  • Example 7 The following samples were prepared according to Example 7 and were made to determine the effect on foam stability and quality at different levels of petrolatum and glycerine.
  • a collapsible foam pre-electric shave lotion very similar to Example 1 in British Patent 1,096,753 to Yardley & Co., Ltd. was prepared as follows:
  • the Polawax A-31 was added to the ethyl alcohol at 110° F. (43.3° C.). Water and the mixture of dimethyl esters of glutaric, succinic and adipic acid was then added to form the intermediate. Dispensing units containing the intermediate were pressurized with the propellant.
  • a pressurized mousse formulation according to Example 6 of U.S. Pat. No. 3,131,152 to Klausner was prepared and tested according to Example 1.
  • the Polowax was dissolved in the ethyl alcohol at 110° F. (43.3° C.). The water and perfume were added while maintaining the same temperature. The units were pressurized with 97% intermediate and 3% of isobutane (A-31) propellant.
  • the cetyl alcohol, Polawax and 1% Veegum were added together and heated until all the Polawax was completely melted.
  • the antiperspirant additives were added (aluminum chlorohydroxide in water and aluminum sulfate), heated to 70° C. and added to the Polawax mixture. The ethanol and fragrance were then added. At 50-60° C. the sample was pressurized with 10% by weight of isobutane propellant.
  • composition formed was a two-phase system and insoluble materials were seen. No foam was produced and the valve clogged.
  • the water, alcohol and Polawax were added to a container and heated to 120° F.-140° F. (48.9° C.-60° C.) until the Polawax completely melted. After the blend cooled down to 100° F.-110° F. (37.8° C.-43.3° C.), the fragrance was added. The intermediate was pressurized in a glass bottle.
  • Formulation KCD 4735 for an aerosol rubbing compound from "Aqueous Alcohol Aerosol Foams", Second Part, by Paul Sanders (noted above) was emulated as follows:
  • test results illustrate the antibacterial effects of the inventive mousse compositions compared to commercial disinfectants and cleansers.
  • fingernails were contaminated by Serratia marcescens and Escherichia coli, respectively.
  • the below products were then applied to the contaminated fingernail regions.
  • Table 2 the column "Untreated” lists the log to the base 10 of the number of colonies of bacteria on the untreated skin. The figures listed are based on an average of 8 measurements. The first number listed for each product is for S. Marcesens and the second is for E. coli.
  • the column “Treated” provides the number of colonies (log base 10) remaining after treatment with 2.5 ml of the applied products.
  • the test results represent the average of 8 tests per product applied. The results indicate the number of bacterial colonies of Serratia marcescens and Escherichia coli, respectively, remaining after the application.
  • the high alcohol content mousse of the invention reduced the bacterial colony count by a factor of almost 10 4 .
  • the present mousse composition showed high efficiency in treating skin contaminated with bacteria and demonstrates the superior antimicrobial activity imparted by the mousse delivery system.

Abstract

This invention relates to a high alcohol content aerosol antimicrobial mousse which is dispensed as a foam for use as an antiseptic. The mousse composition comprises (1) 85-98% of an intermediate concentrate and (2) 2-15% of a hydrocarbon propellant. The intermediate concentrate comprises from 52-75% by weight of ethanol or isopropyl alcohol; from 0.1% to 1.5% by weight of a water-dispersible polymeric gelling agent; an amphiphilic system consisting of from 0.5% to 5.0% by weight of (a) at least one alcohol with a hydrocarbon group of from 16 to 22 carbons and (b) at least one nonionic surfactant, the hydrophilic balance (HLB) of the combination components "a" and "b" is in the range of 4.5 to 8.0 and the balance being at least 20 wt % of water. The hydrocarbon propellant is a saturated aliphatic hydrocarbon having from 2 to 6 carbon atoms.

Description

Technical Field
The invention relates to an aerosol antimicrobial mousse-producing composition with a high level of alcohol as an active ingredient. The composition delivers a stable, disinfecting foam which breaks on pressure application to provide a creamy film of an alcoholic disinfectant.
BACKGROUND ART
It is well known that compositions containing at least 52% by weight of ethanol or isopropyl alcohol are antibacterial and, thus, widely accepted for disinfecting purposes.
Compositions with high alcohol content for disinfecting the hands are available as an antimicrobial alcoholic gel as described in U.S. Pat. No. 4,956,170 to Lee. While using gels to deliver an alcoholic disinfectant is satisfactory for many purposes, nonetheless, where patients have suffered burns or where skin conditions do not permit the spreading of a gel over an area to be treated, there exists a need for an alternate delivery system. That delivery system must be capable of providing disinfectant over an irritated or sensitive area without the pressure required to spread a gel.
In U.S. Pat. No. 2,054,989 to Moore, a semi-solid mass contains alcohol applied to the skin by massaging. The gelling agent used to make the alcohol mass semi-solid may be a soap and a wax. In this semi-solid form the alcoholic composition is dispersed on the skin by rubbing. However, the composition is unsuitable for application to highly sensitive skin.
Alcohol containing moisturizing products dispensed as foams are known, as disclosed in Bennett's The Chemical Formulary, Volume XVI, page 109 (1971), wherein a formulation of a "Fluff-Type Aerosol Moisturizing Cologne" containing 46% alcohol and having a fluorocarbon propellant is recited. The formulation for a Foam-Moisturizing product in The Chemical Formulary, Volume XX, page 194 (1977), includes 35% alcohol, 40% of a 1% solution of Carbopol®941 (as a thickener) neutralized by diisopropanolamine, and a fluorocarbon propellant. Such alcoholic foaming formulations, however, have concentrations of alcohol lower than the 52% concentration normally required for suitable antimicrobial activity. Additionally, use of fluorocarbon propellants is undesirable for the deleterious effect on the environment and the solubility problems they present.
Mousse-forming compositions can be employed to cleanse skin as taught in U.S. Pat. No. 4,806,262 to Snyder. However, such preparations do not possess the high alcohol content required for antibacterial effect. The alcohol employed in amounts to 5% is used as an emollient and a mousse stabilizer. The propellants used in Snyder, nitrous oxide, carbon dioxide and nitrogen do not form a stable foam in the inventive compositions.
As employed herein the term "mousse" includes a composition which is dispensed as a foam and which remains in that form until mechanically compressed as by rubbing or touching. It is, therefore, necessary to provide a stable foam which will not collapse until subjected to the pressure of a mechanical action. However, the presence of alcohols in high concentration, until now, has often caused foams to collapse.
As noted in U.S. Pat. No. 3,131,153 to Klausner, the use of decreasing amounts of alcohol favors the formation of more stable foams. Klausner in Col. 2, lines 42-45, states that by using decreased amounts of alcohol more stable foams are formed. It is said that if more than 64% alcohol is used, then nonhomogeneous compositions are obtained.
U.S. Pat. No. 3,131,152 to Klausner is referred to in a two-part set of articles by Paul Sanders entitled "Aqueous Alcohol Aerosol Foams." The articles appeared in the Aug. 1966 (pp. 56 ff.) and September 1966 (pp. 57 ff.) Drug and Cosmetic Industry. At page 175 of the Sept. 1966 publication, several formulations from the '152 Klausner patent are recited. Among the compositions listed were an aerosol men's cologne foam containing 53% by weight ethanol and an aerosol rubbing compound containing 59.1% by weight ethanol. The propellants used by Sanders were preferred to be chlorofluorocarbons, although aliphatic hydrocarbons are also disclosed. The solubility characteristics of the chlorofluorocarbons differ from the hydrocarbon propellant used in the present invention. Thus, when using chloroflurocarbons, there is a problem of the incomplete solubility of the combination of surfactants in the aerosol. That results in the possibility of valve clogging and the formation of unstable foams. Further, the '152 Klausner patent does not teach use of a polymeric gelling agent or an amphiphilic nonionic stabilizer with a specific HLB.
A readily-collapsible, antiperspirant sprayable foam composition is taught in U.S. Pat. No. 3,395,214 to Mummert. The composition has 20-60% alcohol and 10-70% water. Cetyl alcohol is employed and an ethoxylated stearyl alcohol is used together with a thickener and antiperspirant. Freon, propane or isobutane were employed as the propellants. However, the surfactants employed in Mummert are not completely soluble with hydrocarbon propellants which results in precipitation thereof and clogged valves when the foam is dispensed.
The Mummert foams also disappear within a few seconds after dispensing and before any mechanical working of the dispensed material. The thickener employed in Mummert was a magnesium aluminum silicate ("Veegum"). It is believed that the undesired "Veegum" together with the surfactant used renders the compositions too unstable and unduly insoluble in the aerosol form.
U.S. Pat. No. 476,273 to Grollier et al. teaches an unstable aerosol foam containing cationic and/or anionic polymers that produce a foam in an aqueous solution. The alcohol content (C1-8 alcohol) is said not to be more than 50%.
U.K. Pat. No. 1,096,753 to Yardley & Co. Ltd. (equivalent to U.S. Pat. No. 3,824,303) relates to a collapsible foam pre-electric shave lotion. The foam is formed from a 55-70% water:alcohol solution which contains 0.5 to 5% of a surfactant mixture which is an ester or ether of a higher monohydric or dihydric alcohol having eight or more carbon atoms and a higher alcohol. Hydrocarbon propellants can be used. However, the composition does not form a stable foam, lacks a polymeric gelling agent and does not teach the HLB balance of the present invention.
U.S. Pat. No. 4,627,973 to Moran et al. relates to an aerosol skin mousse containing a combination of moisturizers. The alcohol content is only 15-30% by weight.
U.S. Pat. No. 3,770,648 to Mackles is directed to an anhydrous aerosol foam. Mackles Example I4 relates to a hair cleaning foam containing 45% ethanol and only 5% water. A silicone resin is the foaming agent and a fluorocarbon propellant is used. Examples 16 and 17 disclose anhydrous antiperspirant foams containing 74% and 81% alcohol respectively. A silicone resin is the foaming agent and a fluorocarbon propellant is employed.
U.S. Pat. No. 4,440,653 to Briscoe et al. teaches a stable alcoholic foam to be used as a carrier fluid such as a treating fluid for subterranean oil wells. The composition contains a liquid phase of 50-100% alcohol, which may optionally contain water. A nonionic surfactant and thickening agent, such as guar gum, are combined in the alcoholic solution. The liquid is foamed with a gas or mixture of gases such as air, carbon dioxide or preferably nitrogen. The foam-forming gases used in Briscoe are not hydrocarbon propellants. Briscoe fails to employ an amphiphilic nonionic stabilizer or a higher alcohol and a polyethoxylated fatty alcohol. The foam merely functions to stimulate recovery of hydrocarbons (oil) in subterranean formations.
U.S. Pat. No. 4,511,486 to Shah teaches cleaning dentures with an aerated foam. The foamable liquid cleanser includes 1-10% surfactant, 0.1-10% humectant, 25-60% water and 35-70% ethanol or isopropyl alcohol. The foam is non-pressurized. In use the cleaner is forced into an air-mixer to form a foam.
U.S. Pat. No. 4,808,388 to Beutler et al. relates to a foamable cream for the skin which may be in the form of a mousse. Beutler teaches a creamy, oil-in-water emulsion using nitrous oxide or carbon dioxide as the propellant. Alcohols of long-chain fatty acids in concentrations of 0.5-4.5% are employed, but no ethanol or isopropanol is used.
U.S. Pat. No. 4,673,569 to Shernov et al. is directed to a mousse aerosol hair composition having water and alcohol phases. The alcohol phase includes 0.5% to 20% of an alcohol, such as ethanol, as a secondary solvent. The alcohol phase further contains a long-chain nonionic ester and a foam-forming agent. The water phase contains water, a film-forming resin and a corrosion inhibitor. The mousse composition also contains ammonium hydroxide with isobutane as the propellant.
U.S. Pat. No. 3,840,465 to Knowles et al. discloses a foam-producing composition including an aqueous solution of a foam-producing surfactant containing a propellant dispersed therein. The composition further includes a water-insoluble surfactant which is soluble in the propellant. The foam-producing surfactant is a fatty acid salt or synthetic surfactant and the propellant-soluble surfactant is an ethoxylated compound. The composition provides a very persistent foam which is said to last from 40 to 240 minutes. There is no disclosure of high amounts of alcohol being present nor of the collapse of the foam upon being subjected to pressure.
SUMMARY DISCLOSURE OF THE INVENTION
It is an object of the present invention to provide an alcoholic, disinfecting antimicrobial mousse product, which is readily spread over a subject. It is another object to provide an antimicrobial, alcoholic mousse which does not employ fluorocarbon propellants and is able to provide a stable, creamy foam which is an effective disinfectant upon application.
These and other objects and advantages will be apparent from the following description of the invention. All weights provided herein are based on the total weight of the intermediate concentrate unless otherwise indicated.
This invention encompasses a high alcohol content aerosol antimicrobial mousse composition which includes (I) an intermediate concentrate in amounts from about 85% to 98% of the total weight of the mousse composition and (II) a propellant in amounts from about 2% to 15% of the total weight of the mousse composition. The intermediate concentrate includes from about 52% to 75% by weight of ethanol, isopropanol or mixtures thereof; from about 0.1 to 1.5% by weight of a water-dispersible polymeric gelling agent; from about 1.0% to 15% by weight of an amphiphilic nonionic stabilizer comprising (a) from about 0.5 to 5.0% by weight of at least one alcohol of the formula ROH, wherein R is a hydrocarbon group having from 16 to 22 carbon atoms and (b) from about 0.5% to 10% by weight of at least one nonionic surfactant of the formula R,O(CH2CH20)xH where R' is a hydrocarbon group having from 16 to 22 carbon atoms and x has an average value of 1 to 21, wherein the hydrophilic and lipophilic balance (HLB) of the combination of (a) and (b) is from about 4.5 to 8.0; and the balance being at least about 20% by weight of water.
The propellant is at least one saturated aliphatic hydrocarbon having from 2 to 6 carbon atoms per molecule. The propellant generally has a vapor pressure of about 17 to 108 pounds per square inch (0.12 to 0.74 MegaPascal - "MPa") gauge at 25° C.
The mousse delivery form is superior to a gel delivery form for sensitive skin because the alcohol disinfectant remains stabilized in the dispensed mousse foam for a longer period. The gel, on the other hand, is applied to a small area of the skin and then spread in expanding circles. Since the alcohol tends to evaporate from the gel almost immediately, there is little alcohol left at the edges of the expanding circles. However, when the mousse foam is applied, the alcohol remains stabilized in the mousse for a longer period of time.
BEST MODE FOR CARRYING OUT THE INVENTION
In a preferred embodiment the invention is directed to a high alcohol content mousse adapted for disinfectant and hospital uses. It is recognized by the Food and Drug Administration that a composition having a minimum of about 54% by weight of ethanol is considered to be antimicrobial because it is capable of killing gram positive and gram negative bacteria upon contact. The mousse form of the composition stabilizes the alcohol against immediate evaporation. When a measured amount of the mousse composition is applied to skin previously contaminated with bacteria, the bacterial colony count is typically reduced by a factor on the order of 10,000 times.
The mousse composition of the invention includes an intermediate concentrate of active ingredients and a hydrocarbon propellant for the intermediate concentrate. The intermediate concentrate includes an alcohol, a gelling agent, an amphiphilic nonionic stabilizer, and an aqueous carrier.
The antimicrobial effect of the present invention is best evidenced in the presence of about 52% to 75% by weight of an alcohol, preferably ethanol or isopropyl alcohol, or mixtures thereof. The alcohol may be either pure alcohol or denatured alcohol. A more preferred alcohol is ethanol and, most preferably, a denatured alcohol, Specially Denatured (SD) Alcohol 40-A. SD Alcohol 40-A is anhydrous alcohol which is denatured with t-butyl alcohol and sucrose octaacetate.
In order to provide a stabilized foam (mousse), the intermediate concentrate should contain a gelling agent (or thickening agent). The gelling agent preferably employed is a water-dispersible polymeric gelling agent. A more preferred gelling agent is an addition polymer of acrylic acid crosslinked with an unsaturated polyfunctional agent, such as polyalkyl ether of sucrose. The gelling agent assists in stabilizing the formulation to avoid early crystallization prior to filling in the dispenser. The intermediate concentrate is made thicker by the gelling agent for better mixing with the propellant to thus produce a more stable foam.
Preferred polymeric gelling agents are described in U.S. Pat. Nos. 2,798,053, 3,,133,865 and 4,956,170, the disclosures of which are incorporated by reference. They are also to be found listed in the CTFA (Cosmetic, Toiletry, and Fragrance Association), 3rd Edition, 1982, under the adoptive name "Carbomer." They are commercially available under the tradenames CARBOPOL® 934, 940, 941, 951 from B.F. Goodrich Chemicals Group of Cleveland, Ohio. Carbomer 951 is a more preferred gelling agent. Carbomer 951 is the same product as Carbomer 941, except that it is prepared in a benzene-free system, since the solvent used in its production is ethyl acetate.
Effective gelling agents are also available under the trade names ACRITAMER 934, 940 and 941 from R.I.T.A. Corporation of Crystal Lake, Illinois. Other thickening polymers and gums may be used according to their compatibility with the hydroalcoholic system. Other such suitable gelling agents include cellulosic ether polymers sold by Dow Chemical as Methocel® and hydroxymethyl, hydroxyethyl and hydroxypropyl cellulose gums sold under the mark Aqualon®.
Since the gelling ability of the preferred acrylic polymer thickeners is affected by the high alcohol content of the concentrate, it is best to maintain their gelling capability by neutralizing them. Accordingly, optimum thickening results are attained when the carboxyl groups present in the acrylic acid polymers are neutralized employing a suitable neutralizing agent sufficient to render the polymers more water soluble. Usually, from about 15 to 100% of the carboxyl groups present in the acrylic acid polymer are neutralized. Preferably at least about 50% of the carboxyl groups are neutralized.
Appropriate neutralizing agents include triethanolamine, sodium hydroxide, monoethanolamine and dimethyl stearylamine. Other neutralizing agents may be used, such as HO(Cm H2m)2 NH where m has the value of from 2 to 3 and aminomethyl propanol, aminomethyl propanediol, and ethoxylated amines, i.e., H(OCH2 CH2)xRN(CH2 CH2 O)yH, where R is a hydrocarbon radical having from 10 to 18 carbon atoms and the sum of x+y has an average value of from about 5 to 25. An example of a suitable ethoxylated amine is PEG-25 cocamine (hydrocarbon groups are derived from coconut fatty acid and the sum of x+y is 25). Other examples of suitable ethoxylated amines are polyoxyethylene (5) cocamine ("PEG-5 cocamine"); polyoxyethylene (25) cocamine ("PEG-25 cocamine"); polyoxyethylene (5) octadecylamine ("PEG-5 stearamine"); polyoxyethylene (25) octadecylamine ("PEG-25 stearamine"); polyoxyethylene (5) tallowamine ("PEG-5 tallowamine"); polyoxyethylene (I5) oleylamine ("PEG-15 oleylamine"); polyethylene (5) soyamine ("PEG-5 soyamine"); and polyoxyethylene (25) soyamine ("PEG-I5) soyamine"). A number of these are commercially available under the tradename of ETHOMEEN from Akzo Chemie America, Armak Chemicals of Chicago, Illinois.
The preferred neutralizing agent is triethanolamine (TEA).
The polymeric gelling agent is employed in amounts sufficient to provide the intermediate concentrate with sufficient viscosity, to render it pourable and to form a stabilized foam with the propellants. For this and other purposes from about 0.1 to 1.5% by weight of the water-dispersible polymeric gelling agent is employed. More preferably from about 0.I to 0.8% by weight is employed.
The mousse composition is generally formulated as an emulsion having a water-alcohol phase, which includes the active ingredients. It is believed that a small portion of the hydrocarbon propellant is also solubilized in the water-alcohol phase. The balance of the propellant forms a separate layer. Upon discharge, the propellant solubilized in the water-alcohol phase expands and generates the stable aerosol mousse. For that and other purposes, it is necessary to formulate the mousse composition as a stable emulsion. The amphiphilic system of a long-chain alcohol and a nonionic surfactant, properly HLB balanced, acts to overcome the problem of phase separation when using hydrocarbon propellants and permits the intermediate concentrate to retain sufficient propellant to produce a stable foam upon discharge. In addition, the amphiphilic stabilizer remains stable upon pressurization with propellant and resists the tendency to desolubilize and to release components which could clog the aerosol valve.
The foam viscosity of the mousse foam is an indicator of the stability of the dispensed mousse. The foam viscosity at room temperature (20° -22° C.) should be from 2,000 to 40,000 centipoise --"cps" (2 to 40 pascal seconds --"Pa.s"), preferably from 15,000 to 30,000 cps (15 to 30 Pa.s), as measured by a Brookfield Heliopath digital LVTD Viscosimeter with a T-bar spindle at 12 rpm.
An important feature of the present invention is the presence of a mixture of a relatively long-chain alcohol and at least one nonionic surfactant to form an amphiphilic nonionic stabilizer system. The amphiphilic nonionic stabilizer system provides stable compositions when using the hydrocarbon propellants. The nonionic stabilizers employed are selected so as to have a hydrophile-lipophile balance (HLB) between 4.5 to 8. The HLB between the long-chain alcohol and the nonionic surfactant must be within the range of 4.5 to 8 so as to prevent the water-alcohol actives from desolubilizing and permitting solid precipitants or agglomerates to clog the orifice of the spray container.
In general, the test results have shown that when the HLB of the long-chain alcohol and nonionic emulsifier is between about 4.5 and 8, then the intermediate concentrate is translucent and generally homogeneous. The resulting foam is creamy and exhibits a satisfactory foam viscosity. For example, when the HLB is adjusted to 7.5, a very creamy stable foam with a foam viscosity on the order of 31,000 cps (31 Pa.s) may be obtained. When the HLB value was below about 4.5, then excessively creamy foams were produced which exhibited a reduced foam viscosity. Samples with an HLB value of 4.9 exhibited a creamy foam and yielded generally a viscosity reading of over 20,000 cps (20 Pa.s). Samples with HLB values of 9.7 provided oily or tacky foams with reduced viscosities on the order of 15,000 cps (15 Pa.s).
The long-chain alcohol of the amphiphilic stabilizer has the preferred formula ROH, wherein R is a hydrocarbon group of 16 to 22 carbon atoms. Typical alcohols include cetyl, stearyl, isostearyl, hydroxy stearyl, oleyl, ricinoleyl, behenyl, erucyl and 2-octadecenyl alcohols.
In general, the long-chain alcohol is employed in amounts sufficient to provide stabilizing effects. For this and other purposes, generally about 0.5 to 5% weight and, more preferably, 2.5% to 5.0% is used.
The nonionic surfactant preferably has the formula:
R'O(CH.sub.2 CH.sub.2 O).sub.x H
wherein R' is an aliphatic hydrocarbon group having 16-22 carbons and x has an average value from 1-21. Such surfactants are polyethoxylated fatty alcohols. The R'O-group can be derived from alcohols such as cetyl (C16), stearyl (C18), oleyl (C18), behenyl (C20) and erucyl (C22) alcohols. Lauryl alcohol, a C12 alcohol and myristyl alcohol, a C14 alcohol were unsatisfactory when employed as the fatty alcohol portion of the ethyloxylated fatty alcohol, since little or no foam was produced.
Typical preferred polyethoxylated fatty alcohols are the surfactants sold under the mark "BRIJ" by ICI Americas, Inc. Typical preferred polyethoxylated fatty alcohols include polyethoxylated stearyl alcohol containing an average of 21 moles of ethylene oxide or an average of 2 moles of ethylene oxide.
In general, sufficient amounts of polyethoxylated fatty alcohol are employed to provide a stable intermediate concentrate and a stable foam. For this and other purposes, from about 0.5-10% by weight is employed, more preferably 2.5% by weight.
In order to adjust the HLB within the desired range, more than one nonionic surfactant can be utilized. For example, a combination of polyethylated stearyl alcohol (2 moles ethylene oxide) at 1.875% by weight (HLB =4.9) and polyethoxylated stearyl alcohol (21 moles ethylene oxide) at 0.625% by weight (HLB =15.5) could be employed with cetearyl alcohol and ceteareth-20 (2.5% by weight) to provide an optimum HLB of about 6.75.
The combination of cetearyl alcohol and ceteareth-20 is available under the mark Ritapro 300 from R.I.T.A. Corp. in Crystal Lake, Illinois. Cetearyl alcohol is a combination of a cetyl and stearyl alcohol and ceteareth-20 is a mixture of cetyl ethers and stearyl ethers of polyethylene oxide having an average of about 20 oxide units.
Sufficient water, preferably deionized water, is used to form a stable intermediate concentrate. In general, at least about 20% by weight water is employed.
Compatible foam stabilizing and boosting surfactants can optionally be employed including lactic acid esters of monoglycerides sold under the mark "Lactodan" by Grinsted Products, Inc., of Industrial Airport, Kansas, as well as R'CON(CH2 CH2 OH)yH2-y, where R' is an aliphatic hydrocarbon group of from 16 to 22 carbon atoms and y is 1 or 2. These surfactants include cationic emulsifiers, such as diquaternized tallow imidazoline methosulfate, sold as Sherex Varisoft 6112 (available from Sherex Chemical Co. Inc. in Dublin, Ohio); a triquaternized stearic phospholipid complex sold as Monaquat P-TS (available from Mono Industries, Inc., Patterson, New Jersey); hydroxystearamide propyltriamine salts, such as stearamide diethanolamine cyclamide, sold as Cas Chem Surfactols (available from Cyclo Chemicals Corp., Miami, Florida); lactic acid monoglycerides and food emulsifiers such as glyceryl monostearate, propylene glycol monostearate and sodium stearoyl lactylate.
A more preferred foam booster is a silicone wax or an encapsulated oil, such as stearoxytrimethylsilane and stearyl alcohol sold as Q5-0158A wax from Dow Corning and the 3M Microcapsule Mineral Oil.
Such foam stabilizers and boosters are preferably employed in amounts from about 0.1 to 1.0% by weight of the intermediate concentrate.
The hydrocarbon propellant employed is a saturated hydrocarbon or mixtures thereof. The hydrocarbon should have 2 to 6 carbon atoms and includes ethane, n-propane, n-butane, n-pentane, n-hexane, isopropane, isobutane and mixtures thereof.
The propellant should preferably exert a vapor pressure between about 17 and 108 pounds per square (0.12 to 0.74 MPa) inch gauge at 25° C. For this and other purposes the propellant is employed in amounts from about 2-15% by weight based on the total weight of the mousse composition, and preferably in amounts of about 10% to provide a preferred pressure of 52 p.s.i.g. (0.36 MPa).
Other typical ingredients which may be added to the mousse composition include fragrances, antimicrobial agents, skin protective agents, humectants, medicinal ingredients and other auxiliary materials which are conventionally used in cosmetic compositions.
It has been observed that very lipophilic substances, such as small amounts of silicone fluid, mineral oil, and esters, as, for example, isopropyl palmitate and isopropyl myristate, may disrupt foam stability because of the high solubilization of the main emulsifiers in the composition and should not be employed.
Glycerine, propylene glycol and urea are typical moisturizing agents (i.e., humectants) which may optionally be incorporated into the mousse Medicinal substances such as salicylic acid and boric acid may also be added to the system as well as topical anesthetics, such as lidocaine.
Additional antimicrobial agents, such as chlorhexidine digluconate, may also be added to enhance the antimicrobial properties of the antimicrobial mousse. Chlorhexidine digluconate is a preferred optional ingredient because it provides a long-term residual antimicrobial effect. It may be employed in amounts from about 0.1% to 8% by weight based on the intermediate concentrate.
The intermediate concentrate is employed in amounts from about 85-98% of the total mousse composition, although there may be circumstances which would permit more or less to be used. The intermediate concentrate may be prepared by admixing the ethanol, isopropanol or mixtures thereof with the gelling agent and stirring. Next, in sequence, the water, preferably deionized water, is added; the gelling agent is neutralized as required and the amphiphilic stabilizers are added with heating, if necessary. After cooling, optional volatile ingredients can be added. The intermediate concentrate is then pressurized with the propellant.
INDUSTRIAL APPLICABILITY
Compositions made in accordance with the above invention are employable in institutions such as hospitals, nursing homes and clinics or in the home where frequent contact with sources of bacteria and viruses are possible, and thus, a frequent need for degerming the hands arises. The user simply dispenses a golf ball size of the mousse into the palm and rubs the mousse over the hands until they are dry. The contact with the alcohol degerms the hands and if emollients and/or the humectants are employed, they can reduce the drying effects of the alcohol on the skin.
Typical ingredients employed in the mousse composition include:
Brij®72--Steareth-2 (cetyl ether of polyethylene oxide having an average of about 2 ethylene oxide units) available from ICI Americas, Inc., Wilmington, Delaware.
Brij®721--Steareth-21 (cetyl ether of polyethylene oxide having an average of about 21 ethylene oxide units) available from ICI America, Inc., Wilmington, Delaware.
Carbomer 95--an addition polymer of acrylic acid crosslinked with a polyallyl ether of sucrose available from B.F. Goodrich Chemicals Group, Cleveland, Ohio.
Cyclomide®DS-280 - 1:1 Stearic diethanolamide from Alcolac, Inc.
Klucel®--hydroxy propylcellulose available from Hercules, Inc., Wilmington, Delaware.
Lactodan™ P 22--a lactic acid ester of a monoglyceride available from Grindsted.
Macol® 261-115--a polyethylene glycol ether of stearyl alcohol available from Mazer Chemicals, Inc.
Monaquat™ P-TS--a stearic-based triquatenary phospholipid complex available from Mona Industries Inc. in Patterson, New Jersey.
Myvatex® Texture Lite Food Emulsifier - a combination of glyceryl monostearate, propylene glycol monostearate, and sodium stearoyl lactylate which is available from Eastman Chemical Products, Inc.
Polawax --a self emulsifying wax available from Croda, Inc.
Polawax A-31--composed of higher fatty alcohols such as cetyl and stearyl alcohol in combination with waxy ethylene oxide polymers and is available from Croda, Inc. of New York.
Q5-0158A --silicone wax and stearyl alcohol available from Dow Corning Corporation, Midland, Michigan.
Ritapro®300 (RP-3021)--cetearyl alcohol and ceteareth-20 surfactant from R.I.T.A. Corporation, Crystal Lake, Illinois.
SD Alcohol 40A--anhydrous denatured alcohol.
Triethanolamine (TEA).
Varisoft® 6112--tallow imidazoline methosulfate diquaternary available from Sherex Chemical Co. Inc. in Dublin, Ohio.
Veegum--a magnesium aluminum silicate which gels in water from R.T. Vanderbilt Co., Inc. of Norwalk, CT.
The following examples are set forth for the various preferred embodiments and are not limitative of scope. All parts and percentages are by weight unless otherwise indicated.
EXAMPLE 1
This Example illustrates the production of compositions of the present invention useful as antimicrobial mousse compositions. The ingredients for the composition in parts are as follows:
______________________________________                                    
Ingredients       Amount                                                  
______________________________________                                    
S.D. Alcohol 40-A 60.00                                                   
Carbomer 951      0.20                                                    
Deionized Water   34.50                                                   
TEA (85%)         0.20                                                    
Ritapro 300       5.00                                                    
Fragrance         0.10                                                    
                  100.00                                                  
______________________________________
To prepare the mousse composition the Carbomer 951 was added to the alcohol at room temperature and stirred for five minutes. The deionized water was then added, and the mixture stirred for an additional five minutes. TEA was then added and the mixture again stirred for five minutes. The mixture was then heated to 120° -140° F. (48.9° -60° C.), and the Ritapro 300 was added and stirred until the entire amount was melted. After cooling down to 110° -100° F. (43.3° -37.8° C.), the fragrance was added. The density of the intermediate was found to be 0.842 g/ml.
Prior to pressurization of the intermediate, it was exposed to a vacuum of 13-15 p.s.i. (90-103 KiloPascal-"KPa"). The intermediate was maintained at 100° F (37.8° C.) and pressurized with the propellant, I0% of a combination of 30% isobutane and 70% propane (A-91 Propellant). A final pressure of 96 p.s.i. (0.64 MPa) was obtained and, after pressurization, the unit was well shaken.
The product yielded a creamy stable foam with the following foam density and foam viscosity:
(A) Foam density
The foam density measurement at room temperature (20° -22° C.) was made by transferring 40 ml of foam to a 40 ml container, care being taken to minimize air pockets during the filling of the container.
After 30 seconds, any excess sample was discarded, and the weight of the foam was determined. The foam density was then calculated to be 0.134 g/ml as follows: ##EQU1##
(B) Foam Viscosity
The measurement was made by using a Brookfield Heliopath digital LVTD Viscosimeter. The T-bar spindle E was used at 12 rpm, and measurement was made at room temperature (20° -22° C.) after a period of one minute. The measured viscosity was 22,035 centipoise (22.035 Pa.s).
EXAMPLES 2-6
The following Examples were prepared in the same manner as in Example I except that the levels of Ritapro 300 were varied to determine their effect on foam viscosity.
______________________________________                                    
           Amount                                                         
Ingredients  Ex. 2   Ex. 3   Ex. 4 Ex. 5 Ex. 6                            
______________________________________                                    
S.D. Alcohol 40-A                                                         
             60.00   60.00   60.00 60.00 60.00                            
Carbomer 951 0.20    0.20    0.20  0.20  0.20                             
Deionized Water                                                           
             39.00   38.50   37.00 35.50 34.50                            
TEA (85%)    0.20    0.20    0.20  0.20  0.20                             
Ritapro 300  0.50    1.00    2.50  4.00  5.00                             
Fragrance    0.10    0.10    0.10  0.10  0.10                             
             100.00  100.00  100.00                                       
                                   100.00                                 
                                         100.00                           
______________________________________
The measurements for foam density and foam viscosity for each sample were made as in Example 1.
______________________________________                                    
        Foam      Foam                                                    
Example Density   Viscosity   Foam Evaluation                             
______________________________________                                    
2       0.090     3081 cps    Very wet and airy                           
                  (3.081 Pa.s)                                            
3       0.089     6047 cps    Wet and creamy                              
                  (6.047 Pa.s)                                            
4       0.066     15210 cps   Creamier and puffy                          
                  (15.21 Pa.s)                                            
5       0.055     21762 cps   Soft and creamier                           
                  (21.762 Pa.s)                                           
6       0.053     29094 cps   Creamier and stiff                          
                  (29.094 Pa.s)                                           
______________________________________
The measured foam viscosities were within the general desired range from 2,000 to 40,000 cps (2 to 40 Pa.s). The viscosity measurements and foam quality were more satisfactory when the concentration of Ritapro 300 was in the range of 4-5% weight.
COMPARATIVE EXAMPLES 1-8
The following Comparative Examples 1-8 (CE 1-8) were prepared to show the effect of employing lauryl alcohol, a C12 alcohol (Comparative Examples 1-4) and myristyl alcohol, a C14 alcohol (Comparative Examples 5-8) respectively, on foam viscosity. The amount of Ritapro 300 was reduced in proportion to the amount of lauryl (or myristyl) alcohol added. Formulations C. E. 1-8 were as follows:
______________________________________                                    
           Amount                                                         
Ingredients  C.E. 1   C.E. 2   C.E. 3 C.E. 4                              
______________________________________                                    
S.D. Alcohol 40-A                                                         
             60.00    60.00    60.00  60.00                               
Carbomer 951 0.20     0.20     0.20   0.20                                
Deionized Water                                                           
             34.50    34.50    34.50  34.50                               
TEA (85%)    0.20     0.20     0.20   0.20                                
Ritapro 300  3.75     2.50     1.25   --                                  
Lauryl Alcohol                                                            
             1.25     2.50     3.75   5.00                                
Fragrance    0.10     0.10     0.10   0.10                                
             100.00   100.00   100.00 100.00                              
______________________________________
Comparative Examples 5-8 were prepared in the same manner, except for substituting myristyl alcohol for lauryl alcohol.
In the following Table 1, the measurements for foam density and foam viscosity were made as in Examples 1-6. As is apparent from the results, lauryl alcohol and myristyl alcohol cannot be used in the system of this invention as unsatisfactory foam or no foam at all was produced.
              TABLE 1                                                     
______________________________________                                    
        Foam      Foam                                                    
Example Density   Viscosity   Foam Evaluation                             
______________________________________                                    
CE 1    0.058     14820 cps   unduly airy, slow-                          
                  (14.82 Pa.s)                                            
                              breaking foam                               
CE 2    0.044     10140 cps   wet, very quick-                            
                  (10.14 Pa.s)                                            
                              breaking                                    
CE 3    0         0           no foam                                     
CE 4    0         0           no foam                                     
CE 5    0.056     16770 cps   large bubbles                               
                  (16.77 Pa.s)                                            
CE 6    0.047     6240 cps    runny, wet foam                             
                  (6.24 Pa.s)                                             
CE 7    0         0           no foam                                     
CE 8    0         0           no foam                                     
______________________________________
COMPARATIVE EXAMPLES 9-12
The following Examples were prepared according to the procedure in Example 1 to illustrate the effect of different hydrophilic-lipophilic balance (HLB) values obtained by varying the proportions of the surfactants Brij 72 and Brij 721 in combination with Ritapro 300 and using a propane propellant at high pressure.
______________________________________                                    
           Amount                                                         
Ingredients  CE 9    CE 10   CE 11 CE 12 CE 13                            
______________________________________                                    
SD-Alcohol-40A                                                            
             60.00   60.00   60.00 60.00 60.00                            
Carbomer 951 0.20    0.20    0.20  0.20  0.20                             
Deionized Water                                                           
             34.50   34.50   34.50 34.50 34.50                            
TEA (85%)    0.20    0.20    0.20  0.20  0.20                             
Ritapro 300  2.50    2.50    2.50  2.50  2.50                             
Brij 72      2.50    1.875   1.25  0.625 --                               
Bri 721      --      0.625   1.25  1.875 2.50                             
Fragrance    0.10    0.10    0.10  0.10  0.10                             
             100.00  100.00  100.00                                       
                                   100.00                                 
                                         100.00                           
______________________________________
The HLB and foam characteristics of the samples was as follows:
______________________________________                                    
               Foam     Foam                                              
Example                                                                   
       HLB     Density  Viscosity                                         
                                 Foam Evaluation                          
______________________________________                                    
CE 9   4.9     0.063    43680 cps                                         
                                 creamy                                   
                        (43.68 Pa.s)                                      
CE 10  7.5     0.084    45240 cps                                         
                                 very creamy                              
                        (45.24 Pa.s)                                      
CE 11  9.7     0.075    39000 cps                                         
                                 glossy, creamy,                          
                        (39 Pa.s)                                         
                                 tacky foam                               
CE 12  12.8    0.107    33540 cps                                         
                                 airy, light foam                         
                        (33.54 Pa.s)                                      
CE 13  13.5    0.05     23400 cps                                         
                                 very quick-                              
                        (23.4 Pa.s)                                       
                                 breaking, creamy                         
                                 foam                                     
______________________________________
Comparative Example 9 with an HLB of 4.9 provided creamy foam. At the HLB value of 7.5, a very cream, thick foam was obtained. The higher viscosity provided an extremely creamy foam which remained stable for a longer period of time, thereby increasing the availability of the alcohol due to slower evaporation of the alcohol. The comparative examples with an HLB of values of 9.7, 12.8 and 15.5 provided foams which were either too airy and light or broke too quickly before mechanical working. The purpose of the mousse composition of the present invention is to provide a stable foam which will not break before it is applied to the skin.
COMPARATIVE EXAMPLES 14 and 15
These comparative examples were prepared according to the procedure of Example 1.
______________________________________                                    
                Amount                                                    
Ingredients       CE 14   CE 15                                           
______________________________________                                    
SD-Alcohol-40A    60.00   60.00                                           
Carbomer 951      0.20    0.20                                            
Deionized Water   34.50   34.50                                           
TEA (85%)         0.20    0.20                                            
Ritapro 300       0.00    0.00                                            
Brij 72           5.00    0.00                                            
Brij 721          0.00    5.00                                            
Fragrance         0.10    0.10                                            
                  100.00  100.00                                          
______________________________________
In Comparative Examples 14 and 15, Ritapro 300 was omitted and the Brij 72 and/or Brij 721 was the only nonionic surfactant present. The HLB values for CE 14 and CE 15 were 4.9 and I5.5 respectively. The test results for the mousse compositions containing such surfactants were as follows:
______________________________________                                    
               Foam     Foam                                              
Example                                                                   
       HLB     Density  Viscosity                                         
                                 Foam Evaluation                          
______________________________________                                    
CE 14  4.9     0.085    24180 cps                                         
                                 unduly wet & glossy                      
                        (24.18 Pa.s)                                      
CE 15  15.5    0.0      0.0      no foam                                  
______________________________________
The results, when compared to Comparative Examples 9 and 13, show that the omission of Ritapro-300 results in an unsatisfactory foam system. This indicates that for optimum foam quality the HLB balance must be in the indicated range of from 4.5 to 8.0, and that a fatty alcohol (ROH) with 16-22 carbon atoms must be present.
EXAMPLE 7
The following Example was prepared according to the procedure in Example 1 to show use of a different mixture of hydrocarbons as the propellant.
______________________________________                                    
Ingredients       Amount                                                  
______________________________________                                    
S.D. Alcohol 40-A 60.00                                                   
Carbomer 951      0.20                                                    
Deionized Water   34.50                                                   
TEA (85%)         0.20                                                    
Ritapro 300       2.50                                                    
Brij 72           1.875                                                   
Brij 721          0.625                                                   
Fragrance         0.10                                                    
                  100.00                                                  
______________________________________
Instead of the A-91 Propellant, a B-52 Propellant containing a ratio of 30/30/40 of propane/isobutane/n-butane was used. The foam measurements were made as in Example I with the following results:
Foam density--0.050 g/ml.
Foam Viscosity--30420 cps (30.42 Pa.s)
Foam evaluation--very creamy coated feel.
EXAMPLES 8-2
In the following Examples 8-12, chlorhexidine digluconate was employed as an antimicrobial agent which was added to extend the antimicrobial property of the mousse by providing a long-term residual killing effect. In place of Carbomer 951, which is an anionic water-dispersible polymeric gelling agent, a nonionic cellulosic thickener was used. That was deemed necessary since the chlorhexidine digluconate has a positive charge and may precipitate out the anionic agent. Varying amounts of the chlorhexidine digluconate were employed. The samples were prepared as in Example 7 using B-52 Propellant.
______________________________________                                    
           Amount                                                         
Ingredients  Ex. 8   Ex. 9   Ex. 10                                       
                                   Ex. 11                                 
                                         Ex. 12                           
______________________________________                                    
S.D. Alcohol 40-A                                                         
             60.00   60.00   60.00 60.00 60.00                            
Klucel (hydroxy-                                                          
             0.20    0.20    0.20  0.20  0.20                             
propylcellulose)                                                          
Deionized Water                                                           
             14.62   19.68   24.71 29.76 32.23                            
Ritapro 300  2.50    2.50    2.50  2.50  2.50                             
Brij 72      1.875   1.875   1.875 1.875 1.875                            
Brij 721     0.625   0.625   0.625 0.625 0.625                            
Chlorhexidine                                                             
             20.18   15.12   10.09 5.04  2.57                             
digluconate (20%)                                                         
             100.00  100.00  100.00                                       
                                   100.00                                 
                                         100.00                           
______________________________________
The samples were analyzed and the measurements were made as in Example 1.
______________________________________                                    
          Foam     Foam                                                   
Example   Density  Viscosity   Foam Evaluation                            
______________________________________                                    
 8        0.050    29920 cps   creamy, stable                             
                   (29.92 Pa.s)                                           
 9        0.049    30050 cps   creamy, stable                             
                   (30.05 Pa.s)                                           
10        0.056    29850 cps   creamy, stable                             
                   (29.85 Pa.s)                                           
11        0.048    28750 cps   creamy, stable                             
                   (28.75 Pa.s)                                           
12        0.055    31200 cps   creamy, stable                             
                   (31.20 Pa.s)                                           
______________________________________
The results illustrate that long term antimicrobial effects may be imparted to the mousse composition by the addition of an antimicrobial agent while maintaining the excellent foam characteristics.
EXAMPLE 13
The following example includes a silicone wax and a humectant.
______________________________________                                    
Ingredients        Amount                                                 
______________________________________                                    
SD Alcohol 40-A    60.00                                                  
Carbomer 951       0.20                                                   
Deionized Water    30.50                                                  
TEA (85%)          0.20                                                   
Ritapro 300        5.00                                                   
Q5-0158A (silicone wax)                                                   
                   1.00                                                   
Fragrance          0.10                                                   
Glycerine (humectant)                                                     
                   3.00                                                   
                   100.00                                                 
______________________________________
The mousse compositions were prepared and the foam measurements were made as in Example 1.
______________________________________                                    
Foam        Foam                                                          
Density     Viscosity Foam Evaluation                                     
______________________________________                                    
0.053       31200 cps very creamy                                         
            (31.20 Pa.s)                                                  
______________________________________
Q5-01584 is a foam booster which acts together with the Ritapro 300 to provide a very creamy foam.
EXAMPLES 14-18
The following formulations, prepared according to Example 1, illustrate additional examples of mousse compositions in which various cosmetic additives were also employed.
______________________________________                                    
          Amount                                                          
Ingredients Ex. 14  Ex. 15  Ex. 16 Ex. 17                                 
                                         Ex. 18                           
______________________________________                                    
SD Alcohol 40-A                                                           
            60.00   60.00   60.00  60.00 60.00                            
Carbomer 951                                                              
            0.20    0.20    0.20   0.20  0.20                             
Deionized Water                                                           
            34.50   34.50   34.50  34.50 24.50                            
TEA (85%)   0.20    0.20    0.20   0.20  0.20                             
Ritapro 300 2.50    3.75    3.75   3.75  5.00                             
Myvatex     2.50    --      --     --    --                               
Texture Lite                                                              
Lactodan P22                                                              
            --      1.25    --     --    --                               
Varisoft 6112                                                             
            --      --      1.25   --    --                               
Monaquat P-TS                                                             
            --      --      --     1.25  --                               
Urea        --      --      --     --    10.00                            
Fragrance   0.10    0.10    0.10   0.10  0.10                             
            100.00  100.00  100.00 100.00                                 
                                         100.00                           
______________________________________
In Example 16, after the addition of the Varisoft 6112, a yellow precipitate was observed to form which remained in the viscous gel that formed.
______________________________________                                    
         Foam     Foam        Foam                                        
Example  Density  Viscosity   Evaluation                                  
______________________________________                                    
14       0.12     37440 cps   creamy rich                                 
                  (37.44 Pa.s)                                            
15       0.11     38610 cps   creamy, soft                                
                  (38.61 Pa.s)                                            
16       0.06     17550 cps   creamy foam with                            
                  (17.55 Pa.s)                                            
                              small texture;                              
                              coated skin feel                            
                              after washing                               
17       0.07     19110 cps   creamy foam; coated                         
                  (19.11 Pa.s)                                            
                              skin feel after                             
                              washing                                     
18       0.05     31200 cps   creamy foam; skin                           
                  (31.20 Pa.s)                                            
                              softening feel after                        
                              application                                 
______________________________________
EXAMPLES 19-20
A formulation was prepared according to Example 1 to illustrate the use of a medicinal substance, such as salicylic acid and 2-phenoxyethanol, in the mousse compositions of the invention. The preparation in Example 19 was made and tested as in Example 1 while Example 20 was made as in Example 7. In each example, the ingredients were mixed together in the order listed.
______________________________________                                    
                 Amount                                                   
Ingredients        Ex. 19  Ex. 20                                         
______________________________________                                    
SD-Alcohol-40A     60.00   60.00                                          
Carbomer 951       0.20    0.20                                           
Deionized Water    32.50   32.60                                          
TEA (85%)          0.20    0.20                                           
Ritapro 300        5.00    2.50                                           
Salicylic acid     2.00    --                                             
Fragrance          0.10    --                                             
Brij 72            --      1.875                                          
Brij 721           --      0.625                                          
Q5-0184 (Silicone Wax)                                                    
                   --      0.60                                           
Myvatex Texture Lite                                                      
                   --      0.20                                           
Cyclomide DS-280   --      0.20                                           
2-Phenoxyethanol   --      1.00                                           
                   100.00  100.00                                         
______________________________________                                    

______________________________________                                    
        Foam      Foam                                                    
Example Density   Viscosity  Foam Evaluation                              
______________________________________                                    
19      0.064     31980 cps  creamy, rich texture;                        
                  (31.98 Pa.s)                                            
                             skin soft after                              
                             application                                  
20      0.050     31200 cps  creamy, oily                                 
                  (31.20 Pa.s)                                            
______________________________________
EXAMPLES 21-23
The following samples were prepared according to Example 7 and were made to determine the effect on foam stability and quality at different levels of petrolatum and glycerine.
______________________________________                                    
            Amount                                                        
Ingredients   Ex. 21     Ex. 22  Ex. 23                                   
______________________________________                                    
SD Alcohol 40-A                                                           
              60.00      60.00   60.00                                    
Carbomer 951  0.20       0.20    0.20                                     
Deionized Water                                                           
              29.85      27.60   23.10                                    
Glycerine     1.50       3.00    6.00                                     
TEA (85%)     0.20       0.20    0.20                                     
Petrolatum    0.75       1.50    3.00                                     
Ritapro 300   2.50       2.50    2.50                                     
Brij 72       1.875      1.875   1.875                                    
Brij 721      0.625      0.625   0.625                                    
Myvatex       0.20       0.20    0.20                                     
Texture Lite                                                              
Cyclomide DS-280                                                          
              0.20       0.20    0.20                                     
Q5-0158A      1.00       1.00    1.00                                     
(Silicone Wax)                                                            
Macol 261-115 1.00       1.00    1.00                                     
Fragrance     0.10       0.10    0.10                                     
              100.00     100.00  100.00                                   
______________________________________
The test results for foam density and viscosity were as follows:
______________________________________                                    
          Foam     Foam                                                   
Example   Density  Viscosity   Foam Evaluation                            
______________________________________                                    
21        0.0825   20670 cps   creamy, soft feel                          
                   (20.67 Pa.s)                                           
22        0.0775   20670 cps   creamy, soft feel                          
                   (20.67 Pa.s)                                           
23        0.0575   10920 cps   creamy, soft feel                          
                   (10.92 Pa.s)                                           
______________________________________
The presence of the additional foam boosters and stabilizers Myvatex Texture Lite, Cyclomide DS-280 and Macol 261-115 prevents the petrolatum from interfering with foam stability and quality.
The following comparative tests were performed on comparative aerosol or mousse formulations prepared generally according to the formulas in British Patent 1,096,753, U.S. Pat. No. 3,131,852, U.S. Pat. No. 3,395,214 and in the Paul Sanders' article "Aqueous Alcohol Aerosol Foams" employing the procedures of Example 1.
COMPARATIVE EXAMPLE 15
A collapsible foam pre-electric shave lotion very similar to Example 1 in British Patent 1,096,753 to Yardley & Co., Ltd. was prepared as follows:
______________________________________                                    
Ingredients          Amount                                               
______________________________________                                    
Dimethyl esters of   2.40                                                 
glutaric, adipic and                                                      
succinic acids                                                            
Denatured ethyl alcohol (95%)                                             
                     68.10                                                
Polawax A-31         4.90                                                 
Water                21.90                                                
Isobutane (Propellant)                                                    
                     2.70                                                 
                     100.00                                               
______________________________________
The Polawax A-31 was added to the ethyl alcohol at 110° F. (43.3° C.). Water and the mixture of dimethyl esters of glutaric, succinic and adipic acid was then added to form the intermediate. Dispensing units containing the intermediate were pressurized with the propellant.
The pressurized composition was tested for foam characteristics and the results were as follows:
______________________________________                                    
Foam         Foam                                                         
Density      Viscosity                                                    
                      Foam Evaluation                                     
______________________________________                                    
0            0        no foam formed                                      
______________________________________
COMPARATIVE EXAMPLE 16
A pressurized mousse formulation according to Example 6 of U.S. Pat. No. 3,131,152 to Klausner was prepared and tested according to Example 1.
______________________________________                                    
Intermediate                                                              
Ingredients        Amount                                                 
______________________________________                                    
Polawax            1.5                                                    
Anhydrous ethyl alcohol                                                   
                   58.5                                                   
Perfume            2.0                                                    
Water              38.0                                                   
                   100.0                                                  
______________________________________
The Polowax was dissolved in the ethyl alcohol at 110° F. (43.3° C.). The water and perfume were added while maintaining the same temperature. The units were pressurized with 97% intermediate and 3% of isobutane (A-31) propellant.
The product evaluation results were as follows:
______________________________________                                    
Foam        Foam                                                          
Density     Viscosity Foam Evaluation                                     
______________________________________                                    
0.142       2730 cps  very runny                                          
            (2.73 Pa.s)                                                   
______________________________________
COMPARATIVE EXAMPLE 17
The antiperspirant sprayable foam of U.S. Pat. No. 3,395,214, to Mummert described in the Example set forth in column 3 was prepared using the procedure of Example 1 as follows:
______________________________________                                    
Nonpressurized                                                            
Intermediate           Amount                                             
______________________________________                                    
Cetyl alcohol          1.0                                                
Polawax                4.0                                                
1% Veegum solution     15.0                                               
Aluminum chlorohydroxide                                                  
                       19.5                                               
Aluminum sulfate       7.0                                                
Aluminum chlorohydroxy allantoinate                                       
                       0.5                                                
Ethanol                39.9                                               
Fragrance              0.1                                                
Water                  13.0                                               
______________________________________
The cetyl alcohol, Polawax and 1% Veegum were added together and heated until all the Polawax was completely melted.
In a separate container the antiperspirant additives were added (aluminum chlorohydroxide in water and aluminum sulfate), heated to 70° C. and added to the Polawax mixture. The ethanol and fragrance were then added. At 50-60° C. the sample was pressurized with 10% by weight of isobutane propellant.
The composition formed was a two-phase system and insoluble materials were seen. No foam was produced and the valve clogged.
COMPARATIVE EXAMPLE 18
An aerosol men's cologne foam, Formula KCD-4424, from page 175 of "Aqueous Alcohol Aerosol Foams", Second Part, by Paul Sanders (noted earlier) was prepared as follows:
______________________________________                                    
Ingredients        Amount                                                 
______________________________________                                    
Water              33.0                                                   
Anhydrous ethyl alcohol                                                   
                   53.0                                                   
Polawax            2.0                                                    
Perfume            2.0                                                    
Propellant*        10.0                                                   
(30/30/40 propane/                                                        
isobutane/n-butane-                                                       
B-52 Propellant)   100.0                                                  
______________________________________                                    
 *A hydrocarbon propellant was substituted for the Sanders Freon          
 propellant.
The water, alcohol and Polawax were added to a container and heated to 120° F.-140° F. (48.9° C.-60° C.) until the Polawax completely melted. After the blend cooled down to 100° F.-110° F. (37.8° C.-43.3° C.), the fragrance was added. The intermediate was pressurized in a glass bottle.
The product evaluation results for foam characteristics were as follows:
______________________________________                                    
Foam Density                                                              
            Foam Viscosity                                                
                          Foam Evaluation                                 
______________________________________                                    
0.05        1404 cps      light, large bubbles,                           
            (1.404 Pa.s)  quick breaking                                  
______________________________________
COMPARATIVE EXAMPLE 19
Formulation KCD 4735 for an aerosol rubbing compound from "Aqueous Alcohol Aerosol Foams", Second Part, by Paul Sanders (noted above) was emulated as follows:
______________________________________                                    
Ingredients        Amount                                                 
______________________________________                                    
Water              27.8                                                   
Anhydrous ethyl alcohol                                                   
                   59.1                                                   
Fragrance          0.1                                                    
Polawax            3.0                                                    
Propellant*        10.0                                                   
(30/30/40 propane/                                                        
isobutane, n-butane-                                                      
B-52 Propellant)   100.0                                                  
______________________________________                                    
 *A hydrocarbon propellant was used in place of the Freon propellant of   
 Sanders and a fragrance was substituted for hexachlorophene.
The product evaluation results for foam characteristics were as follows:
______________________________________                                    
Foam Density                                                              
            Foam Viscosity                                                
                          Foam Evaluation                                 
______________________________________                                    
0.055       780 cps       light, large bubbles,                           
            (0.78 Pa.s)   quick breaking                                  
______________________________________
EXAMPLE 20
The following test results illustrate the antibacterial effects of the inventive mousse compositions compared to commercial disinfectants and cleansers. In the tests fingernails were contaminated by Serratia marcescens and Escherichia coli, respectively. The below products were then applied to the contaminated fingernail regions. In Table 2 the column "Untreated" lists the log to the base 10 of the number of colonies of bacteria on the untreated skin. The figures listed are based on an average of 8 measurements. The first number listed for each product is for S. Marcesens and the second is for E. coli. The column "Treated" provides the number of colonies (log base 10) remaining after treatment with 2.5 ml of the applied products. The test results represent the average of 8 tests per product applied. The results indicate the number of bacterial colonies of Serratia marcescens and Escherichia coli, respectively, remaining after the application.
              TABLE 2                                                     
______________________________________                                    
Product       Untreated Treated                                           
______________________________________                                    
Inventive High Alcohol                                                    
              7.12      3.30     S. Marcescens                            
Content Mousse                                                            
              6.37      2.84     E. coli                                  
Alcohol Wipe  7.35      6.31                                              
              6.65      5.70                                              
DELIVER ™ Alcohol                                                      
              7.35      4.08                                              
Gel from S. C. Johnson                                                    
              6.65      3.19                                              
& Son, Inc.                                                               
Ultracol ™ (bacteri-                                                   
              7.51      4.27                                              
cidal alcohol hand gel)                                                   
              6.58      3.71                                              
from Dexide Corpora-                                                      
tion                                                                      
Calstat (bactericidal                                                     
              7.51      4.46                                              
soap) from Calgon                                                         
              6.58      3.44                                              
Corporation                                                               
Ivory Liquid  7.24      5.98                                              
from Procter & Gamble                                                     
              6.68      4.26                                              
Liquid Dial from                                                          
              7.24      6.62                                              
The Dial Corporation                                                      
              6.68      5.44                                              
______________________________________
As can be seen from the above results the high alcohol content mousse of the invention reduced the bacterial colony count by a factor of almost 104. The present mousse composition showed high efficiency in treating skin contaminated with bacteria and demonstrates the superior antimicrobial activity imparted by the mousse delivery system.
The invention is not to be limited except as set forth in the following claims.

Claims (23)

What I claim is:
1. A high alcohol content aerosol antimicrobial mousse composition comprising:
(I) an intermediate concentrate having
(a) from about 52% -75% by weight of the intermediate concentrate of ethanol, isopropanol or mixtures thereof;
(b) from about 0.1%-1.5% by weight of the intermediate concentrate of a water-dispersible polymeric gelling agent;
(c) from about 1% to 15% by weight of the intermediate concentrate of an amphiphilic nonionic stabilizer consisting essentially of
(i) from about 0.5%-5.0% of the intermediate concentrate of at least one alcohol of the formula ROH where R is a hydrocarbon group having from 16 to 22 carbons; and
(ii) from about 0.5%-10% by weight of the intermediate concentrate of at least one nonionic surfactant of the formula R'O(CH2 CH2 O)x H were R' is a hydrocarbon group having from 16 to 22 carbon atoms and x has an average value of from 1 to 21; wherein the hydrophilic-lipophilic balance of the combination of (i) and (ii) is from about 4.5 to 8.0; and
(d) the balance consisting essentially of water in an amount of at least about 20% by weight of the intermediate concentrate; and
(II) a saturated aliphatic hydrocarbon propellant having from 2 to 6 carbon atoms;
wherein the intermediate concentrate (I) is from about 85%-98% of the total aerosol mousse composition and the propellant (II) is from about 2%-15% of the total aerosol mousse composition.
2. The composition according to claim 1, wherein the intermediate concentrate further contains from about 0.1%-10% by weight of stearoxytrimethylsilane.
3. The composition according to claim 1, wherein the intermediate concentrate further contains from about 0.1% to 10% weight of a microencapsulated hydrocarbon oil.
4. The composition according to claim 1, wherein the intermediate concentrate further contains from about 0.1% to 10% by weight of a long-term antimicrobial agent.
5. The composition according to claim 1, wherein the intermediate concentrate further contains from about 0.1% to 10% by weight of a humectant.
6. The composition according to claim 5, wherein the humectant is selected from the group consisting of propylene glycol, glycerine and urea.
7. The composition according to claim 1, wherein the intermediate concentrate further contains from about 0.1% to 10% by weight of a cationic skin conditioning agent.
8. The composition according to claim 1, wherein the intermediate concentrate further contains a medicinal agent.
9. The composition according to claim 8, wherein the medicinal agent is a topical anesthetic.
10. The composition according to claim 8, wherein the medicinal agen tis an antiacne agent.
11. The composition according to claim 1, wherein the intermediate concentrate further contains a sunscreen.
12. The composition according to claim 1, wherein the intermediate concentrate contains an insect repellant.
13. The composition according to claim 1, wherein the alcohol is ethanol.
14. The composition of claim 1, wherein ROH is an alcohol selected from the group consisting of cetyl, stearyl, hydroxystearyl, oleyl, ricinoleyl, behenyl, and erucyl alcohol.
15. The composition of claim 1, wherein the gelling agent is an addition polymer of acrylic acid cross-linked with an unsaturated polyfunctional agent wherein from 15%-100% of acrylic acid carboxyl groups present are neutralized with a base.
16. The composition according to claim 15, wherein the unsaturated polyfunctional agent is a polyallyl ether of sucrose.
17. The composition according to claim 15, wherein the base is selected from an organic amine, sodium hydroxide or ammonium hydroxide.
18. The composition according to claim 17, wherein said base is triethanolamine.
19. The composition according to claim 1, including from about 0.1% to 10% by weight of the intermediate concentrate of at least one compatible foam stabilizing and boosting surfactant selected from the group consisting of lactic acid esters of monoglycerides, R'CON(CH2 CH2 O)y H2-y where R' is an aliphatic hydrocarbon group of from 16 to 22 carbon atoms and y is 1 or 2, a diquaternized tallow imidazoline stearic phospholipid complex, a hydroxystearamide propyltriamine salt, glyceryl monostearate, propylene glycol monostearate and sodium stearoyl lactate.
20. The composition according to claim 19, wherein the surfactant is stearic acid monoesterified with a moiety selected from the group consisting of propylene glycol and glycerine, sodium stearoyl lactylate, and R'CON(CH2 CH2 OH)y H2-y where y is 1 or 2.
21. The composition according to claim 1, wherein the propellant is selected from the group consisting of ethane, n-propane, n-butane, n-pentane, n-hexane, isobutane and isopropane.
22. The composition according to claim 1, wherein the propellant has a vapor pressure of about 17-108 pounds per square inch (0.12-0.74 Mega Pascal) gauge at 25° C.
23. A high alcohol content aerosol antimicrobial mousse composition comprising:
(I) an intermediate concentrate having
(a) from about 52%-75% by weight of the intermediate concentrate of ethanol, isopropanol or mixtures thereof;
(b) from about 0.1%-1.5% by weight of the intermediate concentrate of a water-dispersible polymeric gelling agent;
(c) from about 1% to 15% by weight of the intermediate concentrate of an amphiphilic nonionic stabilizer consisting essentially of
(i) from about 0.5%-5.0% of the intermediate concentrate of at least one alcohol of the formula ROH where R is a hydrocarbon group having from 16 to 22 carbons; and
(ii) from about 0.5%-10% by weight of the intermediate concentrate of at least one nonionic surfactant of the formula R'O(CH2 CH2 O)x H where R' is a hydrocarbon group having from 16 to 22 carbon atoms and x has an average value of from 1 to 21; wherein the hydrophilic-lipophilic balance of the combination of (i) and (ii) is from about 4.5 to 8.0;
(d) from about 0.1% to 10% by weight of a cationic skin conditioning agent selected from the group consisting of a diquaternized tallow imidazoline methosulfate, a triquaternized stearic-phospholipid complex and a hydroxy stearamide propyltriammonium salt; and
(e) the balance consisting essentially of water in an amount at least about 20% by weight of the intermediate concentrate; and
wherein the intermediate concentrate (I) is from about 85%-98% of the total aerosol mousse composition and the propellant (II) is from abut 2%-15% of the total aerosol mousse composition.
US07/676,917 1991-03-28 1991-03-28 High alcohol content aerosol antimicrobial mousse Expired - Fee Related US5167950A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/676,917 US5167950A (en) 1991-03-28 1991-03-28 High alcohol content aerosol antimicrobial mousse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/676,917 US5167950A (en) 1991-03-28 1991-03-28 High alcohol content aerosol antimicrobial mousse

Publications (1)

Publication Number Publication Date
US5167950A true US5167950A (en) 1992-12-01

Family

ID=24716555

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/676,917 Expired - Fee Related US5167950A (en) 1991-03-28 1991-03-28 High alcohol content aerosol antimicrobial mousse

Country Status (1)

Country Link
US (1) US5167950A (en)

Cited By (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376366A (en) * 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
EP0744945A1 (en) * 1993-11-05 1996-12-04 E.R. SQUIBB & SONS, INC. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
EP0792632A1 (en) * 1996-03-01 1997-09-03 L'oreal Pressurized transparent apparatus with a foaming composition containing non ionic and amphoteric surfactants
WO1998030096A1 (en) 1997-01-09 1998-07-16 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
WO1998030244A1 (en) * 1997-01-09 1998-07-16 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
AU694264B2 (en) * 1994-10-21 1998-07-16 Shiseido Company Ltd. Disinfectant composition
WO1998050008A1 (en) * 1997-05-09 1998-11-12 Hercules Incorporated Low voc hair sprays containing cellulose ethers
US5951993A (en) * 1995-06-22 1999-09-14 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
GB2338649A (en) * 1998-06-25 1999-12-29 Brian Francis Hawtin Nasal antiseptic compositions
FR2785537A1 (en) * 1999-03-26 2000-05-12 Blue Skin Sa Antiseptic composition in gel form for disinfecting the skin without using water or soap comprises ethyl alcohol, isopropyl alcohol and a carbomer with gel-forming capability
US6090395A (en) * 1995-06-22 2000-07-18 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6107268A (en) * 1999-04-16 2000-08-22 Kimberly-Clark Worldwide, Inc. Sorbent material
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6299862B1 (en) * 1999-09-02 2001-10-09 Tom Barrow Rapidly drying sanitizing aerosol compositions containing alcohols, isobutane and propane
US6355583B1 (en) 1998-05-30 2002-03-12 Kimberly-Clark Worldwide, Inc. Multi-functional sorbent material
US6417154B1 (en) 1998-05-30 2002-07-09 Kimberly-Clark Worldwide, Inc. Sorbent material
US20020155026A1 (en) * 2001-01-22 2002-10-24 Lins Claudio L.K. Electrostatic disinfectant delivery
US6551577B1 (en) * 1997-05-12 2003-04-22 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
US6582711B1 (en) 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US6623744B2 (en) * 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US20040120915A1 (en) * 2002-12-19 2004-06-24 Kaiyuan Yang Multifunctional compositions for surface applications
US20040131578A1 (en) * 2002-10-21 2004-07-08 Eveready Battery Company, Inc. Antibacterial shaving foam/gel formulations
US20040241099A1 (en) * 2003-05-28 2004-12-02 Popp Karl F. Foamable pharmaceutical compositions and methods for treating a disorder
WO2005030917A1 (en) 2003-09-29 2005-04-07 Ethena Healthcare Inc. High alcohol content gel-like and foaming compositions
WO2005025522A3 (en) * 2003-09-10 2005-08-04 Procter & Gamble Skin care composition
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US20060104912A1 (en) * 1998-09-11 2006-05-18 Connetics Australia Pty Ltd Mousse composition
DE102004062775A1 (en) * 2004-12-21 2006-06-29 Stockhausen Gmbh Alcoholic pump foam
US20060204466A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
US20060263396A1 (en) * 1995-06-22 2006-11-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US20060292080A1 (en) * 1998-09-11 2006-12-28 Connetics Australia Pty Ltd Vitamin formulation
WO2006102004A3 (en) * 2005-03-16 2007-01-11 Taro Pharmaceuticals Usa Inc A stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
EP1764135A1 (en) * 2005-09-19 2007-03-21 Clariant International Ltd. Cold production method for pearly lustre preparations containing alcohols
US20070142260A1 (en) * 2005-12-20 2007-06-21 S.C. Johnson & Son, Inc. Combination air sanitizer, soft surface deodorizer/sanitizer and hard surface disinfectant
US20070138208A1 (en) * 2005-12-16 2007-06-21 3M Innovative Properties Company Dispenser
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition
US20070224143A1 (en) * 2006-03-21 2007-09-27 Kamedis Ltd. Cosmetic and pharmaceutical foam carrier
EP1858323A1 (en) * 2005-03-07 2007-11-28 DEB Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080051312A1 (en) * 2006-08-23 2008-02-28 David Lestage Foamable compositions containing alcohol
US20080207767A1 (en) * 2007-02-23 2008-08-28 Kelly Ann Dobos Foamable Alcoholic Composition
US20080249187A1 (en) * 2002-02-05 2008-10-09 Johnson & Johnson Consumner Companies, Inc. Skin Sanitizing Antimicrobial Alcoholic Compositions
CN100435779C (en) * 2003-09-10 2008-11-26 宝洁公司 Skin care composition
US20080311053A1 (en) * 2007-06-14 2008-12-18 Mason Chemical Company Fluorinated phosphate ester surfactant and fluorinated alcohol compositions
US20080317697A1 (en) * 2007-06-21 2008-12-25 Thomas Arthur Sturgis Shaving kit and method of shaving comprising a personal care composition and an in shower body lotion
US20090149473A1 (en) * 1997-10-17 2009-06-11 Stiefel Research Australia Pty Ltd. Topical antifungal composition
US20090180970A1 (en) * 2002-10-25 2009-07-16 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US7651990B2 (en) 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US20100022654A1 (en) * 2006-10-27 2010-01-28 Asmus Robert A Antimicrobial compositions
US20100022660A1 (en) * 2008-07-24 2010-01-28 Ecolab Inc. Foaming alcohol compositions with selected dimethicone surfactants
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20100189809A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Compositions Containing Alcohol
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20100317743A1 (en) * 2009-06-15 2010-12-16 Macinga David R Methods and compositions for use with gel dispensers
US20110014135A1 (en) * 2005-06-01 2011-01-20 Stiefel Research Australia Pty Ltd Vitamin formulation
US20110144214A1 (en) * 2007-10-30 2011-06-16 Marcia Snyder Hydroalcoholic gel compositions for use with dispensers
WO2011087489A1 (en) 2009-12-22 2011-07-21 S. C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
WO2012154547A1 (en) 2011-05-06 2012-11-15 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8741373B2 (en) 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
EP2740467A1 (en) * 2012-12-10 2014-06-11 OTC GmbH Pumpable cosmetic composition with a high humectant content and foaming properties
US8754024B1 (en) * 2013-02-26 2014-06-17 Michael Scott Fishman Liquefied-gas aerosol dusting composition containing sucrose octaacetate
US8765661B2 (en) 2008-03-20 2014-07-01 Virun, Inc. Compositions containing non-polar compounds
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20150080478A1 (en) * 2012-03-30 2015-03-19 Gojo Industries, Inc. Antimicrobial alcohol foam compositions and methods of preparation
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
WO2016007451A1 (en) * 2014-07-11 2016-01-14 Medtronic Xomed, Inc. Antimicrobial wash
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320295B2 (en) 2010-03-23 2016-04-26 Virun, Inc. Compositions containing non-polar compounds
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CN108601726A (en) * 2015-12-15 2018-09-28 治疗学有限公司 Foam compositions and preparation method thereof containing corticosteroid
WO2018231863A1 (en) * 2017-06-12 2018-12-20 Lakewood Amedex, Inc Bisphosphocin gel formulations and uses thereof
US10220007B2 (en) 2008-03-20 2019-03-05 Virun, Inc. Compositions containing non-polar compounds
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2019174867A1 (en) * 2018-03-13 2019-09-19 Unilever N.V. A sanitizer composition
US10674722B2 (en) 2012-02-24 2020-06-09 Gojo Industries, Inc. Antimicrobial and foamable alcoholic compositions
US10869862B2 (en) 2016-05-26 2020-12-22 Conopco, Inc. Antimicrobial compositions for topical use
US10874122B2 (en) 2012-02-10 2020-12-29 Virun, Inc. Beverage compositions containing non-polar compounds
US11123357B2 (en) 2018-10-17 2021-09-21 Lakewood Amedex, Inc. Methods and compositions for treating oral mucositis
US11185080B2 (en) 2014-04-30 2021-11-30 Matoke Holdings Limited Antimicrobial compositions
WO2022034386A1 (en) * 2020-08-14 2022-02-17 Prof4Skin Gmbh Alcohol-based disinfectant foam
GR1010243B (en) * 2021-02-02 2022-06-01 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ", Stable antiseptic skin-cleansing water-alcohol foam
US11628129B2 (en) 2017-04-04 2023-04-18 Gojo Industries, Inc. Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems
US11730168B2 (en) 2017-10-16 2023-08-22 Matoke Holdings Limited Antimicrobial superabsorbent compositions
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
US3131152A (en) * 1960-06-13 1964-04-28 Allied Chem Foam producing formulations
US3131153A (en) * 1961-10-25 1964-04-28 Allied Chem Foam producing compositions
US3282776A (en) * 1965-05-17 1966-11-01 Johnson & Son Inc S C Aerosol germicidal compositions
GB1096753A (en) * 1965-05-10 1967-12-29 Yardley & Company Ltd Collapsible foam pre-electric shave lotion
US3395214A (en) * 1964-01-09 1968-07-30 Scholl Mfg Co Inc Antiperspirant composition providing a readily collapsible sprayable foam
US3395215A (en) * 1964-10-15 1968-07-30 Colgate Palmolive Co Pressurized lotion composition
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
US3824303A (en) * 1963-07-24 1974-07-16 Yardley Of London Inc Collapsible foam pre-electric shave lotion containing diester lubricants
US3840465A (en) * 1970-11-18 1974-10-08 Texaco Inc Aerosol foam composition
US3922977A (en) * 1973-08-02 1975-12-02 Gen Foods Corp Plant husbandry
US3962150A (en) * 1974-04-10 1976-06-08 Richardson-Merrell Inc. Foam producing cleansing compositions
US4145411A (en) * 1974-09-05 1979-03-20 Colgate-Palmolive Company Pressurized foaming shaving composition
US4224319A (en) * 1979-07-31 1980-09-23 Ernest Marcadet Antiseptic composition for topical application to the skin
US4440653A (en) * 1982-03-08 1984-04-03 Halliburton Company Highly stable alcohol foams and methods of forming and using such foams
US4464293A (en) * 1982-04-12 1984-08-07 Dobrin Robert J Liquid cleaner-disinfectant composition for use in wiping down dental operatories
US4511486A (en) * 1981-11-02 1985-04-16 Richardson-Vicks Inc. Method of cleaning dentures using aerated foams
US4574052A (en) * 1984-05-31 1986-03-04 Richardson-Vicks Inc. Crackling aerosol foam
US4627973A (en) * 1984-12-14 1986-12-09 Charles Of The Ritz Group Ltd. Skin mousse
US4661340A (en) * 1983-06-06 1987-04-28 Interkemia Vegyipari Gazdasagi Tarsasag Quail egg based stabilized foam compositions for cosmetic purposes
US4673569A (en) * 1985-02-12 1987-06-16 Faberge Incorporated Mousse hair composition
US4683004A (en) * 1985-08-20 1987-07-28 Union Carbide Corporation Foamable compositions and processes for use thereof
US4708813A (en) * 1985-08-14 1987-11-24 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US4761273A (en) * 1981-05-08 1988-08-02 L'oreal Composition in the form of an aerosol foam, based on a cationic polymer and an anionic polymer
US4798722A (en) * 1986-11-12 1989-01-17 Zotos International, Inc. Permanent waving composition
US4806262A (en) * 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US4808388A (en) * 1986-08-20 1989-02-28 Merz + Co. Gmbh & Co. Foamable creams
US4956170A (en) * 1989-06-28 1990-09-11 S. C. Johnson & Son, Inc. Skin moisturizing/conditioning antimicrobial alcoholic gels
US4981677A (en) * 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
US5002680A (en) * 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits

Patent Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
US3131152A (en) * 1960-06-13 1964-04-28 Allied Chem Foam producing formulations
US3131153A (en) * 1961-10-25 1964-04-28 Allied Chem Foam producing compositions
US3824303A (en) * 1963-07-24 1974-07-16 Yardley Of London Inc Collapsible foam pre-electric shave lotion containing diester lubricants
US3395214A (en) * 1964-01-09 1968-07-30 Scholl Mfg Co Inc Antiperspirant composition providing a readily collapsible sprayable foam
US3395215A (en) * 1964-10-15 1968-07-30 Colgate Palmolive Co Pressurized lotion composition
GB1096753A (en) * 1965-05-10 1967-12-29 Yardley & Company Ltd Collapsible foam pre-electric shave lotion
US3282776A (en) * 1965-05-17 1966-11-01 Johnson & Son Inc S C Aerosol germicidal compositions
US3840465A (en) * 1970-11-18 1974-10-08 Texaco Inc Aerosol foam composition
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
US3922977A (en) * 1973-08-02 1975-12-02 Gen Foods Corp Plant husbandry
US3962150A (en) * 1974-04-10 1976-06-08 Richardson-Merrell Inc. Foam producing cleansing compositions
US4145411A (en) * 1974-09-05 1979-03-20 Colgate-Palmolive Company Pressurized foaming shaving composition
US4224319A (en) * 1979-07-31 1980-09-23 Ernest Marcadet Antiseptic composition for topical application to the skin
US4761273A (en) * 1981-05-08 1988-08-02 L'oreal Composition in the form of an aerosol foam, based on a cationic polymer and an anionic polymer
US4511486A (en) * 1981-11-02 1985-04-16 Richardson-Vicks Inc. Method of cleaning dentures using aerated foams
US4440653A (en) * 1982-03-08 1984-04-03 Halliburton Company Highly stable alcohol foams and methods of forming and using such foams
US4464293A (en) * 1982-04-12 1984-08-07 Dobrin Robert J Liquid cleaner-disinfectant composition for use in wiping down dental operatories
US4661340A (en) * 1983-06-06 1987-04-28 Interkemia Vegyipari Gazdasagi Tarsasag Quail egg based stabilized foam compositions for cosmetic purposes
US4574052A (en) * 1984-05-31 1986-03-04 Richardson-Vicks Inc. Crackling aerosol foam
US4627973A (en) * 1984-12-14 1986-12-09 Charles Of The Ritz Group Ltd. Skin mousse
US4673569A (en) * 1985-02-12 1987-06-16 Faberge Incorporated Mousse hair composition
US5002680A (en) * 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
US4708813A (en) * 1985-08-14 1987-11-24 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US4806262A (en) * 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US4683004A (en) * 1985-08-20 1987-07-28 Union Carbide Corporation Foamable compositions and processes for use thereof
US4808388A (en) * 1986-08-20 1989-02-28 Merz + Co. Gmbh & Co. Foamable creams
US4798722A (en) * 1986-11-12 1989-01-17 Zotos International, Inc. Permanent waving composition
US4981677A (en) * 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
US4956170A (en) * 1989-06-28 1990-09-11 S. C. Johnson & Son, Inc. Skin moisturizing/conditioning antimicrobial alcoholic gels

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"A Formulary of Cosmetic Preparation", M. Ash et al., Chemical Publishing Co., New York, N.Y., 1977, pp. 98-100.
"Aqueous Alcohol Aerosol Foams, Parts I & II", P. Sanders, Drug & Cosmetic Industry, Aug., 1966, p. 56ff and Sep., 1966, p. 57ff.
"The Chemical Formulary, vol. XVI", H. Bennett, Chemical Publishing Co., Inc., New York, N.Y., 1971, p. 109.
"The Chemical Formulary, vol. XX", H. Bennett, Chemical Publishing Co., Inc., New York, N.Y., 1977, p. 194.
A Formulary of Cosmetic Preparation , M. Ash et al., Chemical Publishing Co., New York, N.Y., 1977, pp. 98 100. *
Aqueous Alcohol Aerosol Foams, Parts I & II , P. Sanders, Drug & Cosmetic Industry, Aug., 1966, p. 56ff and Sep., 1966, p. 57ff. *
The Chemical Formulary, vol. XVI , H. Bennett, Chemical Publishing Co., Inc., New York, N.Y., 1971, p. 109. *
The Chemical Formulary, vol. XX , H. Bennett, Chemical Publishing Co., Inc., New York, N.Y., 1977, p. 194. *

Cited By (279)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508029A (en) * 1992-11-12 1996-04-16 John Petchul Isopropyl alcohol gel composition and process for preparing same
US5376366A (en) * 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
EP0744945A1 (en) * 1993-11-05 1996-12-04 E.R. SQUIBB & SONS, INC. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
EP0744945A4 (en) * 1993-11-05 1998-09-09 Squibb & Sons Inc Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
AU694264B2 (en) * 1994-10-21 1998-07-16 Shiseido Company Ltd. Disinfectant composition
US5800827A (en) * 1994-10-21 1998-09-01 Shiseido Co., Ltd. Disinfectant composition
US6090395A (en) * 1995-06-22 2000-07-18 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6534069B1 (en) 1995-06-22 2003-03-18 3M Innovative Properties Company Stable hydroalcoholic compositions
EP1407761A1 (en) * 1995-06-22 2004-04-14 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6623744B2 (en) * 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US6610315B2 (en) 1995-06-22 2003-08-26 3M Innovative Properties Company Topical application of stable hydroalcoholic compositions for maintaining or improving skin conditions, and delivering fragrance to skin
US6562360B2 (en) 1995-06-22 2003-05-13 3M Innovative Properties Company Stable hydroalcoholic compositions
EP2322137A1 (en) 1995-06-22 2011-05-18 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6352701B1 (en) 1995-06-22 2002-03-05 3M Innovative Properties Company Stable hydroalcoholic compositions
US5951993A (en) * 1995-06-22 1999-09-14 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US20060263396A1 (en) * 1995-06-22 2006-11-23 3M Innovative Properties Company Stable hydroalcoholic compositions
EP2314272A1 (en) 1995-06-22 2011-04-27 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US7566460B2 (en) 1995-06-22 2009-07-28 3M Innovative Properties Company Stable hydroalcoholic compositions
US20040071748A1 (en) * 1995-06-22 2004-04-15 3M Innovative Properties Company Stable hydroalcoholic compositions
US7081246B2 (en) * 1995-06-22 2006-07-25 3M Innovative Properties Company Stable hydroalcoholic compositions
US7803390B2 (en) 1995-06-22 2010-09-28 3M Innovative Properties Company Stable hydroalcoholic compositions
EP0792632A1 (en) * 1996-03-01 1997-09-03 L'oreal Pressurized transparent apparatus with a foaming composition containing non ionic and amphoteric surfactants
FR2745496A1 (en) * 1996-03-01 1997-09-05 Oreal Pressurised dispenser for cosmetic skin care and cleansing foam
WO1997031615A1 (en) * 1996-03-01 1997-09-04 L'oreal Pressurised transparent device for a foaming composition including non-ionic and amphoteric surfactants
US5888478A (en) * 1996-03-01 1999-03-30 L'oreal Transparent pressurized device with foaming composition including nonionic and amphoteric surfactants
CN1082802C (en) * 1996-03-01 2002-04-17 莱雅公司 Pressurised transparent device for foaming composition including non-ionic and amphoteric surfactants
EP1464222A2 (en) * 1997-01-09 2004-10-06 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
AU733138B2 (en) * 1997-01-09 2001-05-10 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
WO1998030244A1 (en) * 1997-01-09 1998-07-16 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
EP1464222A3 (en) * 1997-01-09 2005-02-16 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US8062649B2 (en) 1997-01-09 2011-11-22 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US6582711B1 (en) 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US5908619A (en) * 1997-01-09 1999-06-01 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
WO1998030096A1 (en) 1997-01-09 1998-07-16 Minnesota Mining And Manufacturing Company Hydroalcoholic compositions thickened using surfactant/polymer complexes
WO1998050008A1 (en) * 1997-05-09 1998-11-12 Hercules Incorporated Low voc hair sprays containing cellulose ethers
US6551577B1 (en) * 1997-05-12 2003-04-22 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
US20090149473A1 (en) * 1997-10-17 2009-06-11 Stiefel Research Australia Pty Ltd. Topical antifungal composition
US8586066B2 (en) 1997-10-17 2013-11-19 Delcor Asset Corporation Topical antifungal composition
US7553835B1 (en) * 1997-10-17 2009-06-30 Stiefel Research Australia Pty Ltd Topical antifungal composition
US8026238B2 (en) 1997-10-17 2011-09-27 Stiefel Research Australia, Pty Ltd Topical antifungal composition
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US6562777B2 (en) 1998-05-30 2003-05-13 Kimberly-Clark Worldwide, Inc. Sorbent material
US6417154B1 (en) 1998-05-30 2002-07-09 Kimberly-Clark Worldwide, Inc. Sorbent material
US6355583B1 (en) 1998-05-30 2002-03-12 Kimberly-Clark Worldwide, Inc. Multi-functional sorbent material
GB2338649A (en) * 1998-06-25 1999-12-29 Brian Francis Hawtin Nasal antiseptic compositions
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US20060104912A1 (en) * 1998-09-11 2006-05-18 Connetics Australia Pty Ltd Mousse composition
US20060292080A1 (en) * 1998-09-11 2006-12-28 Connetics Australia Pty Ltd Vitamin formulation
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
FR2785537A1 (en) * 1999-03-26 2000-05-12 Blue Skin Sa Antiseptic composition in gel form for disinfecting the skin without using water or soap comprises ethyl alcohol, isopropyl alcohol and a carbomer with gel-forming capability
US6107268A (en) * 1999-04-16 2000-08-22 Kimberly-Clark Worldwide, Inc. Sorbent material
US6299862B1 (en) * 1999-09-02 2001-10-09 Tom Barrow Rapidly drying sanitizing aerosol compositions containing alcohols, isobutane and propane
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7674429B2 (en) * 2001-01-22 2010-03-09 Johnsondiversey, Inc. Electrostatic disinfectant delivery
US20020155026A1 (en) * 2001-01-22 2002-10-24 Lins Claudio L.K. Electrostatic disinfectant delivery
US8329758B2 (en) * 2002-02-05 2012-12-11 Gojo Industries, Inc. Skin sanitizing antimicrobial alcoholic compositions
US20080249187A1 (en) * 2002-02-05 2008-10-09 Johnson & Johnson Consumner Companies, Inc. Skin Sanitizing Antimicrobial Alcoholic Compositions
US20040131578A1 (en) * 2002-10-21 2004-07-08 Eveready Battery Company, Inc. Antibacterial shaving foam/gel formulations
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9622947B2 (en) * 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20090180970A1 (en) * 2002-10-25 2009-07-16 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20040120915A1 (en) * 2002-12-19 2004-06-24 Kaiyuan Yang Multifunctional compositions for surface applications
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8119106B2 (en) 2003-04-28 2012-02-21 Foamix Ltd Foamable iodine compositions
US20040241099A1 (en) * 2003-05-28 2004-12-02 Popp Karl F. Foamable pharmaceutical compositions and methods for treating a disorder
US7829107B2 (en) 2003-05-28 2010-11-09 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20070059253A1 (en) * 2003-05-28 2007-03-15 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US9636405B2 (en) * 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8114385B2 (en) * 2003-08-04 2012-02-14 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20110002857A1 (en) * 2003-08-04 2011-01-06 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20130189193A1 (en) * 2003-08-04 2013-07-25 Foamix Ltd. Foamable Vehicle and Pharmaceutical Compositions Thereof
US8518378B2 (en) * 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
CN100435779C (en) * 2003-09-10 2008-11-26 宝洁公司 Skin care composition
WO2005025522A3 (en) * 2003-09-10 2005-08-04 Procter & Gamble Skin care composition
US8569219B2 (en) 2003-09-29 2013-10-29 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions comprising an anionic phosphate fluorosurfactant
US20050129626A1 (en) * 2003-09-29 2005-06-16 Koivisto Bruce M. High alcohol content gel-like and foaming compositions
US7199090B2 (en) 2003-09-29 2007-04-03 Ethena Healthcare Inc. High alcohol content gel-like and foaming compositions comprising an alcohol and fluorosurfactant
EP3428257A1 (en) 2003-09-29 2019-01-16 Deb IP Limited High alcohol content gel-like and foaming compositions
US8940674B2 (en) 2003-09-29 2015-01-27 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions
US7683018B2 (en) 2003-09-29 2010-03-23 Deb Worldwide Healthcare Inc. High alcohol content gel-like and foaming compositions comprising an anionic phosphate fluorosurfactant
WO2005030917A1 (en) 2003-09-29 2005-04-07 Ethena Healthcare Inc. High alcohol content gel-like and foaming compositions
WO2006066888A3 (en) * 2004-12-21 2006-10-12 Stockhausen Chem Fab Gmbh Pumped foam containing alcohol
US20060182690A1 (en) * 2004-12-21 2006-08-17 Stockhausen Gmbh Alcoholic pump foam
WO2006066888A2 (en) * 2004-12-21 2006-06-29 Stockhausen Gmbh Pumped foam containing alcohol
US8697103B2 (en) 2004-12-21 2014-04-15 Deb Ip Limited Alcoholic pump foam
US7670615B2 (en) 2004-12-21 2010-03-02 Stockhausen Gmbh Alcoholic pump foam
US20100069505A1 (en) * 2004-12-21 2010-03-18 Stockhausen Gmbh Alcoholic pump foam
DE102004062775A1 (en) * 2004-12-21 2006-06-29 Stockhausen Gmbh Alcoholic pump foam
CN101083908B (en) * 2004-12-21 2012-04-25 戴博Ip有限公司 Pumped foam containing alcohol
US8124115B2 (en) 2004-12-21 2012-02-28 Dep Ip Limited Alcoholic pump foam
EP1858323A1 (en) * 2005-03-07 2007-11-28 DEB Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
EP1858323A4 (en) * 2005-03-07 2013-04-17 Deb Worldwide Healthcare Inc High alcohol content foaming compositions with silicone-based surfactants
US8263098B2 (en) 2005-03-07 2012-09-11 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
EP3292757A1 (en) 2005-03-07 2018-03-14 Deb IP Limited High alcohol content foaming compositions with silicone-based surfactants
US8309111B2 (en) 2005-03-07 2012-11-13 Deb Worldwide Healthcare Inc. High alcohol content foaming compositions with silicone-based surfactants
KR101455554B1 (en) * 2005-03-07 2014-10-27 디이비 월드와이드 헬스케어 인코포레이티드 High alcohol content foaming compositions with silicone-based surfactants
US8313758B2 (en) 2005-03-07 2012-11-20 Deb Worldwide Healthcare Inc. Method of producing high alcohol content foaming compositions with silicone-based surfactants
US20110201693A1 (en) * 2005-03-08 2011-08-18 Ecolab Usa Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20080293825A1 (en) * 2005-03-08 2008-11-27 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20060204466A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20060204467A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
WO2006102004A3 (en) * 2005-03-16 2007-01-11 Taro Pharmaceuticals Usa Inc A stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US8298515B2 (en) 2005-06-01 2012-10-30 Stiefel Research Australia Pty Ltd. Vitamin formulation
US8629128B2 (en) 2005-06-01 2014-01-14 Stiefel West Coast, Llc Vitamin formulation
US20110014135A1 (en) * 2005-06-01 2011-01-20 Stiefel Research Australia Pty Ltd Vitamin formulation
US7651990B2 (en) 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
EP1764135A1 (en) * 2005-09-19 2007-03-21 Clariant International Ltd. Cold production method for pearly lustre preparations containing alcohols
US20070065385A1 (en) * 2005-09-19 2007-03-22 Clariant International, Ltd. Cold production method for pearly lustre preparations containing alcohols
US20070138208A1 (en) * 2005-12-16 2007-06-21 3M Innovative Properties Company Dispenser
US20070142260A1 (en) * 2005-12-20 2007-06-21 S.C. Johnson & Son, Inc. Combination air sanitizer, soft surface deodorizer/sanitizer and hard surface disinfectant
US7307053B2 (en) 2005-12-20 2007-12-11 S.C. Johnson & Son, Inc. Combination air sanitizer, soft surface deodorizer/sanitizer and hard surface disinfectant
AU2006252070B2 (en) * 2005-12-28 2011-08-11 Gojo Industries Inc. Foamable alcoholic composition
EP1811013A1 (en) * 2005-12-28 2007-07-25 Gojo Industries, Inc. Foamable alcoholic composition
AU2006252070C1 (en) * 2005-12-28 2013-12-19 Gojo Industries Inc. Foamable alcoholic composition
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition
EP2113556A3 (en) * 2005-12-28 2010-03-31 Gojo Industries, Inc. Foamable alcoholic composition
US20070224143A1 (en) * 2006-03-21 2007-09-27 Kamedis Ltd. Cosmetic and pharmaceutical foam carrier
US20100189611A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Composition Containing Alcohol
US20100189809A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Compositions Containing Alcohol
US8354364B2 (en) 2006-08-23 2013-01-15 The Clorox Company Foamable composition containing alcohol
US20080051312A1 (en) * 2006-08-23 2008-02-28 David Lestage Foamable compositions containing alcohol
US20100187263A1 (en) * 2006-08-23 2010-07-29 The Clorox Company Foamable Composition Containing Alcohol
US7723279B2 (en) 2006-08-23 2010-05-25 The Clorox Company Foamable compositions containing alcohol
US7790663B2 (en) 2006-08-23 2010-09-07 The Clorox Company Foamable composition containing alcohol
US8338491B2 (en) 2006-10-27 2012-12-25 3M Innovative Properties Company Antimicrobial compositions
US8569384B2 (en) 2006-10-27 2013-10-29 3M Innovative Properties Company Antimicrobial compositions
US20100022654A1 (en) * 2006-10-27 2010-01-28 Asmus Robert A Antimicrobial compositions
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080207767A1 (en) * 2007-02-23 2008-08-28 Kelly Ann Dobos Foamable Alcoholic Composition
US8580860B2 (en) 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
US20080311053A1 (en) * 2007-06-14 2008-12-18 Mason Chemical Company Fluorinated phosphate ester surfactant and fluorinated alcohol compositions
US20080317697A1 (en) * 2007-06-21 2008-12-25 Thomas Arthur Sturgis Shaving kit and method of shaving comprising a personal care composition and an in shower body lotion
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8822547B2 (en) 2007-10-30 2014-09-02 Gojo Industries, Inc. Hydroalcoholic gel compositions for use with dispensers
US20110144214A1 (en) * 2007-10-30 2011-06-16 Marcia Snyder Hydroalcoholic gel compositions for use with dispensers
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8765661B2 (en) 2008-03-20 2014-07-01 Virun, Inc. Compositions containing non-polar compounds
US10668029B2 (en) 2008-03-20 2020-06-02 Virun, Inc. Compositions containing non-polar compounds
US10220007B2 (en) 2008-03-20 2019-03-05 Virun, Inc. Compositions containing non-polar compounds
US9788564B2 (en) 2008-03-20 2017-10-17 Virun, Inc. Compositions containing non-polar compounds
US8383686B2 (en) 2008-07-24 2013-02-26 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US20100022660A1 (en) * 2008-07-24 2010-01-28 Ecolab Inc. Foaming alcohol compositions with selected dimethicone surfactants
US20100234475A1 (en) * 2008-07-24 2010-09-16 Ecolab Usa Inc Foaming alcohol compositions with selected dimethicone surfactants
US8530524B2 (en) 2008-07-24 2013-09-10 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US9414586B2 (en) 2008-07-24 2016-08-16 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US9980483B2 (en) 2008-07-24 2018-05-29 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US10499636B2 (en) 2008-07-24 2019-12-10 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
US8658701B2 (en) 2008-07-24 2014-02-25 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US8058315B2 (en) 2008-07-24 2011-11-15 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US8940797B2 (en) 2008-07-24 2015-01-27 Ecolab Usa Inc. Foaming alcohol compositions with selected dimethicone surfactants
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10271548B2 (en) 2009-06-15 2019-04-30 Gojo Industries, Inc. Methods and compositions for use with gel dispensers
US10130093B2 (en) 2009-06-15 2018-11-20 Gojo Industries, Inc. Methods and compositions for use with gel dispensers
US10004227B2 (en) 2009-06-15 2018-06-26 Gojo Industries, Inc. Methods and compositions for use with gel dispensers
US10278388B2 (en) 2009-06-15 2019-05-07 Gojo Industries, Inc. Methods and compositions for use with gel dispensers
US9907304B2 (en) 2009-06-15 2018-03-06 Gojo Industries, Inc. Antimicrobial compositions
US9402393B2 (en) 2009-06-15 2016-08-02 Gojo Industries, Inc. Methods and compositions for use with gel dispensers
US20100317743A1 (en) * 2009-06-15 2010-12-16 Macinga David R Methods and compositions for use with gel dispensers
US10285399B2 (en) 2009-06-15 2019-05-14 Gojo Industries, Inc. Methods and compositions for use with gel dispensers
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
WO2011087489A1 (en) 2009-12-22 2011-07-21 S. C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US9320295B2 (en) 2010-03-23 2016-04-26 Virun, Inc. Compositions containing non-polar compounds
US10335385B2 (en) 2010-06-21 2019-07-02 Virun, Inc. Composition containing non-polar compounds
US8741373B2 (en) 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
WO2012154547A1 (en) 2011-05-06 2012-11-15 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US10874122B2 (en) 2012-02-10 2020-12-29 Virun, Inc. Beverage compositions containing non-polar compounds
US10674722B2 (en) 2012-02-24 2020-06-09 Gojo Industries, Inc. Antimicrobial and foamable alcoholic compositions
US11737457B2 (en) 2012-02-24 2023-08-29 Gojo Industries, Inc. Antimicrobial and foamable alcoholic compositions
US9516877B2 (en) * 2012-03-30 2016-12-13 Gojo Industries, Inc. Antimicrobial alcohol foam compositions and methods of preparation
US20150080478A1 (en) * 2012-03-30 2015-03-19 Gojo Industries, Inc. Antimicrobial alcohol foam compositions and methods of preparation
US9943080B2 (en) 2012-03-30 2018-04-17 Gojo Industries, Inc. Antimicrobial alcohol foam compositions and methods of preparation
JP2015512402A (en) * 2012-03-30 2015-04-27 ゴジョ・インダストリーズ・インコーポレイテッド Antibacterial alcohol foam composition and preparation method thereof
EP2740467A1 (en) * 2012-12-10 2014-06-11 OTC GmbH Pumpable cosmetic composition with a high humectant content and foaming properties
US8754024B1 (en) * 2013-02-26 2014-06-17 Michael Scott Fishman Liquefied-gas aerosol dusting composition containing sucrose octaacetate
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
US10786436B2 (en) 2013-06-06 2020-09-29 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
US10588836B2 (en) 2013-06-06 2020-03-17 Ecolab Usa Inc. Alcohol hand sanitizer with improved dermal compatibility and feel
US9962323B2 (en) 2013-06-06 2018-05-08 Ecolab Usa Inc. Alcohol hand sanitizer with improved dermal compatibility and feel
US11464721B2 (en) 2013-06-06 2022-10-11 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
US11311017B2 (en) 2014-04-30 2022-04-26 Matoke Holdings Limited Antimicrobial compositions
US11185080B2 (en) 2014-04-30 2021-11-30 Matoke Holdings Limited Antimicrobial compositions
WO2016007451A1 (en) * 2014-07-11 2016-01-14 Medtronic Xomed, Inc. Antimicrobial wash
EP3289874A1 (en) * 2014-07-11 2018-03-07 Medtronic Xomed, Inc. Antimicrobial wash
US9848604B2 (en) 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
US10681910B2 (en) 2014-07-11 2020-06-16 Medtronic Xomed, Inc. Antimicrobial wash
CN108601726A (en) * 2015-12-15 2018-09-28 治疗学有限公司 Foam compositions and preparation method thereof containing corticosteroid
US11020407B2 (en) * 2015-12-15 2021-06-01 Mayne Pharma Llc Corticosteroid containing foam compositions and method of manufacture thereof
US10869862B2 (en) 2016-05-26 2020-12-22 Conopco, Inc. Antimicrobial compositions for topical use
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11628129B2 (en) 2017-04-04 2023-04-18 Gojo Industries, Inc. Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems
WO2018231863A1 (en) * 2017-06-12 2018-12-20 Lakewood Amedex, Inc Bisphosphocin gel formulations and uses thereof
US11096954B2 (en) 2017-06-12 2021-08-24 Lakewood Amedex, Inc. Bisphosphocin gel formulations and uses thereof
US11730168B2 (en) 2017-10-16 2023-08-22 Matoke Holdings Limited Antimicrobial superabsorbent compositions
CN111787903A (en) * 2018-03-13 2020-10-16 荷兰联合利华有限公司 Disinfectant composition
WO2019174867A1 (en) * 2018-03-13 2019-09-19 Unilever N.V. A sanitizer composition
CN111787903B (en) * 2018-03-13 2023-08-15 联合利华知识产权控股有限公司 Disinfectant composition
US11123357B2 (en) 2018-10-17 2021-09-21 Lakewood Amedex, Inc. Methods and compositions for treating oral mucositis
WO2022034386A1 (en) * 2020-08-14 2022-02-17 Prof4Skin Gmbh Alcohol-based disinfectant foam
GR1010243B (en) * 2021-02-02 2022-06-01 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ", Stable antiseptic skin-cleansing water-alcohol foam

Similar Documents

Publication Publication Date Title
US5167950A (en) High alcohol content aerosol antimicrobial mousse
JP7308247B2 (en) High alcohol content foamable composition containing a silicone-based surfactant
US7683018B2 (en) High alcohol content gel-like and foaming compositions comprising an anionic phosphate fluorosurfactant
US20020160029A1 (en) Stable hydroalcoholic compositions
WO1996000564A1 (en) Four-component aerosol composition
JPH09157637A (en) Aerosol composition
MXPA06003498A (en) High alcohol content gel-like and foaming compositions

Legal Events

Date Code Title Description
AS Assignment

Owner name: S.C. JOHNSON & SON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:LINS, CLAUDIO L. K.;REEL/FRAME:005683/0818

Effective date: 19910328

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20041201